Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	voltage-gated monoatomic cation channel activity	CACNG8 KCNA1 KCNA2 KCNA3 KCNJ6 KCNJ9 CACNG4	3.18e-05	152	117	7	GO:0022843
GeneOntologyMolecularFunction	protein-ribulosamine 3-kinase activity	FN3KRP FN3K	3.40e-05	2	117	2	GO:0102193
GeneOntologyMolecularFunction	voltage-gated monoatomic ion channel activity	CACNG8 KCNA1 KCNA2 KCNA3 KCNJ6 KCNJ9 CACNG4	9.93e-05	182	117	7	GO:0005244
GeneOntologyMolecularFunction	voltage-gated channel activity	CACNG8 KCNA1 KCNA2 KCNA3 KCNJ6 KCNJ9 CACNG4	1.06e-04	184	117	7	GO:0022832
GeneOntologyMolecularFunction	voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential	KCNA1 KCNA2 KCNJ6	1.26e-04	17	117	3	GO:0099508
GeneOntologyMolecularFunction	G-protein activated inward rectifier potassium channel activity	KCNJ6 KCNJ9	2.03e-04	4	117	2	GO:0015467
GeneOntologyMolecularFunction	protein phosphatase regulator activity	PPP2R2D PPP2R2A PPP2R2B PPP2R2C PPP2R3A	3.06e-04	100	117	5	GO:0019888
GeneOntologyMolecularFunction	voltage-gated potassium channel activity	KCNA1 KCNA2 KCNA3 KCNJ6 KCNJ9	3.36e-04	102	117	5	GO:0005249
GeneOntologyMolecularFunction	calcium ion binding	LPCAT1 AOC1 ENPP2 MATN1 CASQ2 PKD1L2 PPP2R3A FBLN2 CELSR3 LRP1 C1R PLCB3 BAIAP3	4.48e-04	749	117	13	GO:0005509
GeneOntologyMolecularFunction	voltage-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential	KCNA1 KCNA2	5.03e-04	6	117	2	GO:1905030
GeneOntologyMolecularFunction	4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity	FUT9 FUT5	5.03e-04	6	117	2	GO:0017083
GeneOntologyMolecularFunction	phosphatase regulator activity	PPP2R2D PPP2R2A PPP2R2B PPP2R2C PPP2R3A	5.38e-04	113	117	5	GO:0019208
GeneOntologyMolecularFunction	delayed rectifier potassium channel activity	KCNA1 KCNA2 KCNA3	5.77e-04	28	117	3	GO:0005251
GeneOntologyMolecularFunction	alpha-(1->3)-fucosyltransferase activity	FUT9 FUT5	9.31e-04	8	117	2	GO:0046920
GeneOntologyMolecularFunction	monoatomic cation channel activity	PKD1L2 CACNG8 KCNA1 KCNA2 KCNA3 KCNJ6 KCNJ9 CACNG4	9.40e-04	343	117	8	GO:0005261
GeneOntologyMolecularFunction	potassium channel activity	KCNA1 KCNA2 KCNA3 KCNJ6 KCNJ9	9.45e-04	128	117	5	GO:0005267
GeneOntologyBiologicalProcess	receptor localization to synapse	VPS26B CACNG8 NETO2 HRAS MKLN1 CACNG4	1.87e-05	101	112	6	GO:0097120
GeneOntologyBiologicalProcess	regulation of presynaptic membrane potential	KCNA1 KCNA2 KCNJ6 KCNJ9	2.63e-05	32	112	4	GO:0099505
GeneOntologyBiologicalProcess	regulation of postsynaptic membrane neurotransmitter receptor levels	VPS26B CACNG8 SNX6 NETO2 HRAS LRP1 CACNG4	3.18e-05	164	112	7	GO:0099072
GeneOntologyCellularComponent	protein phosphatase type 2A complex	PPP2R2D PPP2R2A PPP2R2B PPP2R2C PPP2R3A	4.25e-08	18	118	5	GO:0000159
GeneOntologyCellularComponent	phosphatase complex	PPP2R2D PPP2R2A PPP2R2B PPP2R2C PPP2R3A	1.46e-05	55	118	5	GO:1903293
GeneOntologyCellularComponent	protein serine/threonine phosphatase complex	PPP2R2D PPP2R2A PPP2R2B PPP2R2C PPP2R3A	1.46e-05	55	118	5	GO:0008287
GeneOntologyCellularComponent	glutamatergic synapse	VPS26B ARHGAP39 PPP2R2A CACNG8 MAPK14 KCNA1 KCNA2 KCNA3 CELSR3 SNX6 NETO2 HRAS LRP1 CACNG4 RIMS2	5.69e-05	817	118	15	GO:0098978
GeneOntologyCellularComponent	synaptic membrane	CACNG8 KCNA1 KCNA2 KCNA3 CELSR3 NETO2 KCNJ6 KCNJ9 MKLN1 LRP1 CACNG4 RIMS2	1.15e-04	583	118	12	GO:0097060
GeneOntologyCellularComponent	subcortical maternal complex	TLE6 NLRP5	1.88e-04	4	118	2	GO:0106333
GeneOntologyCellularComponent	retromer complex	VPS26B TBC1D5 SNX6	2.17e-04	21	118	3	GO:0030904
GeneOntologyCellularComponent	cation channel complex	CASQ2 CACNG8 KCNA1 KCNA2 KCNA3 KCNJ6 CACNG4	3.80e-04	235	118	7	GO:0034703
GeneOntologyCellularComponent	postsynaptic endosome	VPS26B SNX6 MKLN1	4.15e-04	26	118	3	GO:0098845
GeneOntologyCellularComponent	postsynaptic membrane	CACNG8 KCNA1 KCNA2 KCNA3 CELSR3 NETO2 MKLN1 LRP1 CACNG4	4.90e-04	405	118	9	GO:0045211
GeneOntologyCellularComponent	postsynapse	VPS26B ARHGAP39 CACNG8 KCNA1 KCNA2 KCNA3 CELSR3 SNX6 NETO2 KCNJ6 MKLN1 LRP1 PLCB3 CACNG4 LNX1	6.13e-04	1018	118	15	GO:0098794
GeneOntologyCellularComponent	postsynaptic early endosome	VPS26B SNX6	6.51e-04	7	118	2	GO:0098842
GeneOntologyCellularComponent	postsynaptic specialization membrane	CACNG8 CELSR3 NETO2 MKLN1 LRP1 CACNG4	9.90e-04	201	118	6	GO:0099634
GeneOntologyCellularComponent	presynaptic membrane	KCNA1 KCNA2 KCNA3 CELSR3 KCNJ6 KCNJ9 RIMS2	1.00e-03	277	118	7	GO:0042734
GeneOntologyCellularComponent	calyx of Held	KCNA1 KCNA2 KCNA3	1.09e-03	36	118	3	GO:0044305
GeneOntologyCellularComponent	monoatomic ion channel complex	CASQ2 CACNG8 KCNA1 KCNA2 KCNA3 KCNJ6 KCNJ9 CACNG4	1.38e-03	378	118	8	GO:0034702
GeneOntologyCellularComponent	recycling endosome	HFE VPS26B ATP9A TUBG1 DENND6A BAIAP3	1.65e-03	222	118	6	GO:0055037
GeneOntologyCellularComponent	voltage-gated potassium channel complex	KCNA1 KCNA2 KCNA3 KCNJ6	1.77e-03	91	118	4	GO:0008076
GeneOntologyCellularComponent	membrane protein complex	HFE VPS26B TBC1D5 CASQ2 STT3A CACNG8 KCNA1 KCNA2 KCNA3 CD6 SNX6 KCNJ6 KCNJ9 ATP6V1D LRP1 CACNG4 C5 NNT	1.83e-03	1498	118	18	GO:0098796
GeneOntologyCellularComponent	postsynaptic density membrane	CACNG8 CELSR3 NETO2 LRP1 CACNG4	1.98e-03	157	118	5	GO:0098839
GeneOntologyCellularComponent	juxtaparanode region of axon	KCNA1 KCNA2	2.01e-03	12	118	2	GO:0044224
GeneOntologyCellularComponent	L-type voltage-gated calcium channel complex	CACNG8 CACNG4	2.01e-03	12	118	2	GO:1990454
GeneOntologyCellularComponent	GATOR2 complex	CASTOR1 MIOS	2.01e-03	12	118	2	GO:0061700
GeneOntologyCellularComponent	potassium channel complex	KCNA1 KCNA2 KCNA3 KCNJ6	2.87e-03	104	118	4	GO:0034705
GeneOntologyCellularComponent	transmembrane transporter complex	CASQ2 CACNG8 KCNA1 KCNA2 KCNA3 KCNJ6 KCNJ9 ATP6V1D CACNG4	2.88e-03	523	118	9	GO:1902495
HumanPheno	Linear nevus sebaceous	KRAS NRAS HRAS	4.15e-07	3	39	3	HP:0010817
HumanPheno	Nevus sebaceous	KRAS NRAS HRAS	4.11e-06	5	39	3	HP:0010815
Domain	PP2A_PR55_CS	PPP2R2D PPP2R2A PPP2R2B PPP2R2C	1.68e-09	4	121	4	IPR018067
Domain	PP2A_PR55	PPP2R2D PPP2R2A PPP2R2B PPP2R2C	1.68e-09	4	121	4	IPR000009
Domain	PR55_2	PPP2R2D PPP2R2A PPP2R2B PPP2R2C	1.68e-09	4	121	4	PS01025
Domain	PR55_1	PPP2R2D PPP2R2A PPP2R2B PPP2R2C	1.68e-09	4	121	4	PS01024
Domain	K_chnl_volt-dep_Kv1	KCNA1 KCNA2 KCNA3	1.45e-05	8	121	3	IPR003972
Domain	Fructosamin_kin	FN3KRP FN3K	4.16e-05	2	121	2	PF03881
Domain	Fructo-/Ketosamine-3-kinase	FN3KRP FN3K	4.16e-05	2	121	2	IPR016477
Domain	Gamma_tubulin	TUBG2 TUBG1	4.16e-05	2	121	2	IPR002454
Domain	DUF1220	NBPF1 NBPF9 NBPF14	4.21e-05	11	121	3	PF06758
Domain	NBPF_dom	NBPF1 NBPF9 NBPF14	4.21e-05	11	121	3	IPR010630
Domain	NBPF	NBPF1 NBPF9 NBPF14	4.21e-05	11	121	3	PS51316
Domain	MAPK_p38	MAPK14 MAPK11	2.48e-04	4	121	2	IPR008352
Domain	K_chnl_volt-dep_Kv	KCNA1 KCNA2 KCNA3	6.93e-04	27	121	3	IPR003968
Domain	ANATO	FBLN2 C5	8.56e-04	7	121	2	SM00104
Domain	ANAPHYLATOXIN_2	FBLN2 C5	8.56e-04	7	121	2	PS01178
Domain	ANAPHYLATOXIN_1	FBLN2 C5	8.56e-04	7	121	2	PS01177
Domain	ANATO	FBLN2 C5	8.56e-04	7	121	2	PF01821
Domain	Anaphylatoxin/fibulin	FBLN2 C5	8.56e-04	7	121	2	IPR000020
Domain	Glyco_transf_10	FUT9 FUT5	1.14e-03	8	121	2	PF00852
Domain	Glyco_tran_10_N	FUT9 FUT5	1.14e-03	8	121	2	PF17039
Domain	Glyco_tran_10_N	FUT9 FUT5	1.14e-03	8	121	2	IPR031481
Domain	VDCC_gsu	CACNG8 CACNG4	1.14e-03	8	121	2	IPR008368
Domain	Glyco_trans_10	FUT9 FUT5	1.14e-03	8	121	2	IPR001503
Domain	EGF_CA	MATN1 FBLN2 CELSR3 LRP1 C1R	1.19e-03	122	121	5	SM00179
Domain	VG_K_chnl	KCNA1 KCNA2 KCNA3	1.26e-03	33	121	3	IPR028325
Domain	EGF-like_Ca-bd_dom	MATN1 FBLN2 CELSR3 LRP1 C1R	1.28e-03	124	121	5	IPR001881
Domain	DUF1220	NBPF1 NBPF9	1.45e-03	9	121	2	SM01148
Domain	RAS	KRAS NRAS HRAS	1.49e-03	35	121	3	PS51421
Domain	Small_GTPase_Ras	KRAS NRAS HRAS	1.75e-03	37	121	3	IPR020849
Domain	Leu-rich_rpt_4	FLII NLRC5	1.81e-03	10	121	2	IPR025875
Domain	LRR_4	FLII NLRC5	1.81e-03	10	121	2	PF12799
Domain	LDLR_class-A_CS	DGCR2 NETO2 LRP1	2.20e-03	40	121	3	IPR023415
Domain	WD_REPEATS_1	PPP2R2D NBAS PPP2R2A PPP2R2B PPP2R2C MIOS TLE6	2.24e-03	278	121	7	PS00678
Domain	WD_REPEATS_2	PPP2R2D NBAS PPP2R2A PPP2R2B PPP2R2C MIOS TLE6	2.29e-03	279	121	7	PS50082
Domain	WD_REPEATS_REGION	PPP2R2D NBAS PPP2R2A PPP2R2B PPP2R2C MIOS TLE6	2.29e-03	279	121	7	PS50294
Domain	EGF_CA	MATN1 FBLN2 LRP1 C1R	2.36e-03	86	121	4	PF07645
Domain	MAPK	MAPK14 MAPK11	2.63e-03	12	121	2	PS01351
Domain	MAP_kinase_CS	MAPK14 MAPK11	2.63e-03	12	121	2	IPR003527
Domain	Ldl_recept_a	DGCR2 NETO2 LRP1	3.09e-03	45	121	3	PF00057
Domain	-	DGCR2 NETO2 LRP1	3.29e-03	46	121	3	4.10.400.10
Domain	LDLRA_1	DGCR2 NETO2 LRP1	3.71e-03	48	121	3	PS01209
Domain	LDrepeatLR_classA_rpt	DGCR2 NETO2 LRP1	3.93e-03	49	121	3	IPR002172
Domain	LDLa	DGCR2 NETO2 LRP1	3.93e-03	49	121	3	SM00192
Domain	LDLRA_2	DGCR2 NETO2 LRP1	3.93e-03	49	121	3	PS50068
Domain	ASX_HYDROXYL	FBLN2 CELSR3 LRP1 C1R	4.07e-03	100	121	4	PS00010
Domain	Ig_E-set	FLNC KCNJ6 KCNJ9 TGM7	4.68e-03	104	121	4	IPR014756
Domain	IRK	KCNJ6 KCNJ9	4.71e-03	16	121	2	PF01007
Domain	K_chnl_inward-rec_Kir_cyto	KCNJ6 KCNJ9	4.71e-03	16	121	2	IPR013518
Domain	-	KCNJ6 KCNJ9	4.71e-03	16	121	2	2.60.40.1400
Domain	K_chnl_inward-rec_Kir	KCNJ6 KCNJ9	4.71e-03	16	121	2	IPR016449
Domain	BTB_2	KCNA1 KCNA2 KCNA3	4.91e-03	53	121	3	PF02214
Domain	T1-type_BTB	KCNA1 KCNA2 KCNA3	4.91e-03	53	121	3	IPR003131
Domain	EGF-type_Asp/Asn_hydroxyl_site	FBLN2 CELSR3 LRP1 C1R	5.01e-03	106	121	4	IPR000152
Domain	NAP_family	NAP1L1 NAP1L4	5.31e-03	17	121	2	IPR002164
Domain	NAP	NAP1L1 NAP1L4	5.31e-03	17	121	2	PF00956
Domain	C345C	NTN4 C5	5.31e-03	17	121	2	SM00643
Domain	-	PPP2R2D NBAS PPP2R2A PPP2R2B PPP2R2C MIOS TLE6	6.01e-03	333	121	7	2.130.10.10
Domain	Channel_four-helix_dom	KCNA1 KCNA2 KCNA3	6.02e-03	57	121	3	IPR027359
Domain	-	KCNA1 KCNA2 KCNA3	6.02e-03	57	121	3	1.20.120.350
Domain	WD40/YVTN_repeat-like_dom	PPP2R2D NBAS PPP2R2A PPP2R2B PPP2R2C MIOS TLE6	6.20e-03	335	121	7	IPR015943
Domain	EGF_1	MATN1 NTN4 FBLN2 CELSR3 LRP1 C1R	6.36e-03	255	121	6	PS00022
Pathway	REACTOME_P38MAPK_EVENTS	KRAS NRAS MAPK14 HRAS MAPK11	1.17e-08	13	90	5	M1441
Pathway	REACTOME_P38MAPK_EVENTS	KRAS MAPK14 HRAS MAPK11	5.36e-08	7	90	4	MM14672
Pathway	REACTOME_SIGNALLING_TO_ERKS	KRAS NRAS RAPGEF1 MAPK14 HRAS MAPK11	6.66e-08	34	90	6	M13881
Pathway	KEGG_MEDICUS_REFERENCE_PP2A_AKT_SIGNALING_PATHWAY	PPP2R2D PPP2R2A PPP2R2B PPP2R2C PPP2R3A	1.03e-07	19	90	5	M47525
Pathway	REACTOME_SIGNALLING_TO_RAS	KRAS NRAS MAPK14 HRAS MAPK11	1.36e-07	20	90	5	M12256
Pathway	KEGG_MEDICUS_REFERENCE_CD80_CD86_CTLA4_PP2A_SIGNALING_PATHWAY	PPP2R2D PPP2R2A PPP2R2B PPP2R2C PPP2R3A	2.29e-07	22	90	5	M47919
Pathway	REACTOME_SIGNALLING_TO_ERKS	KRAS RAPGEF1 MAPK14 HRAS MAPK11	5.61e-07	26	90	5	MM14716
Pathway	REACTOME_SIGNALLING_TO_RAS	KRAS MAPK14 HRAS MAPK11	7.39e-07	12	90	4	MM14657
Pathway	WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING	KRAS NRAS MAPK14 HRAS MAPK11	8.30e-07	28	90	5	M39572
Pathway	WP_MAPK_CASCADE	KRAS NRAS MAPK14 HRAS PLCB3	8.30e-07	28	90	5	MM15976
Pathway	REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS	KRAS NRAS RAPGEF1 HRAS	1.48e-06	14	90	4	M27908
Pathway	KEGG_TIGHT_JUNCTION	KRAS NRAS PPP2R2D PPP2R2A PPP2R2B PPP2R2C HRAS OCLN	1.94e-06	132	90	8	M11355
Pathway	WP_MAPK_CASCADE	KRAS NRAS MAPK14 HRAS PLCB3	1.95e-06	33	90	5	M39594
Pathway	REACTOME_ACTIVATION_OF_RAS_IN_B_CELLS	KRAS NRAS HRAS	2.49e-06	5	90	3	M26921
Pathway	BIOCARTA_BARRESTIN_SRC_PATHWAY	KCNA1 KCNA2 KCNA3 HRAS	3.47e-06	17	90	4	M111
Pathway	REACTOME_ESTROGEN_STIMULATED_SIGNALING_THROUGH_PRKCZ	KRAS NRAS HRAS	4.96e-06	6	90	3	M27951
Pathway	KEGG_MEDICUS_VARIANT_LOSS_OF_RASSF1_TO_RAS_RASSF1_SIGNALING_PATHWAY	KRAS NRAS HRAS	4.96e-06	6	90	3	M47433
Pathway	KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RAS_UBIQUITINATION_BY_CUL3_COMPLEX	KRAS NRAS HRAS	4.96e-06	6	90	3	M47931
Pathway	KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_SPRED_AND_NF1	KRAS NRAS HRAS	4.96e-06	6	90	3	M47932
Pathway	PID_ER_NONGENOMIC_PATHWAY	KRAS NRAS HRAS PLCB3 MAPK11	5.23e-06	40	90	5	M41
Pathway	PID_CXCR3_PATHWAY	KRAS NRAS MAPK14 HRAS MAPK11	7.54e-06	43	90	5	M222
Pathway	WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3	KRAS NRAS MAPK14 HRAS PLCB3 MAPK11	8.09e-06	75	90	6	M39568
Pathway	REACTOME_RAS_SIGNALING_DOWNSTREAM_OF_NF1_LOSS_OF_FUNCTION_VARIANTS	KRAS NRAS HRAS	8.65e-06	7	90	3	M29717
Pathway	REACTOME_SOS_MEDIATED_SIGNALLING	KRAS NRAS HRAS	8.65e-06	7	90	3	M19489
Pathway	KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RASGAP	KRAS NRAS HRAS	1.38e-05	8	90	3	M47935
Pathway	REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_RAS	KRAS NRAS HRAS	1.38e-05	8	90	3	M27919
Pathway	REACTOME_SIGNALING_BY_ERYTHROPOIETIN	KRAS NRAS RAPGEF1 HRAS	1.77e-05	25	90	4	M27865
Pathway	REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN	KRAS NRAS HRAS	2.06e-05	9	90	3	M27156
Pathway	REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R	KRAS NRAS HRAS	2.06e-05	9	90	3	M27173
Pathway	REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_RAS	KRAS NRAS HRAS	2.06e-05	9	90	3	M27904
Pathway	PID_IL2_1PATHWAY	KRAS NRAS MAPK14 HRAS MAPK11	2.56e-05	55	90	5	M122
Pathway	REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION	KRAS NRAS RAPGEF1 HRAS	3.27e-05	29	90	4	M779
Pathway	REACTOME_MET_ACTIVATES_RAS_SIGNALING	KRAS NRAS HRAS	4.00e-05	11	90	3	M27740
Pathway	REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE	KRAS NRAS HRAS	4.00e-05	11	90	3	M27535
Pathway	KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY	KRAS NRAS HRAS	4.00e-05	11	90	3	M47370
Pathway	KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY	KRAS NRAS HRAS	4.00e-05	11	90	3	M47371
Pathway	REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2	KRAS NRAS HRAS	4.00e-05	11	90	3	M29814
Pathway	KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RALGDS_SIGNALING_PATHWAY	KRAS NRAS HRAS	4.00e-05	11	90	3	M47436
Pathway	KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RASSF1_SIGNALING_PATHWAY	KRAS NRAS HRAS	4.00e-05	11	90	3	M47432
Pathway	REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FRS2_AND_FRS3	KRAS NRAS HRAS	4.00e-05	11	90	3	M27911
Pathway	WP_IL6_SIGNALING_PATHWAY	PPP2R2A PPP2R2B PPP2R2C PPP2R3A MAPK14 HRAS	4.22e-05	100	90	6	MM15826
Pathway	KEGG_GNRH_SIGNALING_PATHWAY	KRAS NRAS MAPK14 HRAS PLCB3 MAPK11	4.46e-05	101	90	6	M1979
Pathway	REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION	KRAS NRAS CACNG8 KCNJ6 KCNJ9 HRAS PLCB3 CACNG4	4.87e-05	205	90	8	M752
Pathway	REACTOME_SIGNALING_BY_NTRK1_TRKA	KRAS RAPGEF1 MAPK14 HRAS MAPK11	4.98e-05	63	90	5	MM14714
Pathway	KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY	KRAS NRAS HRAS	5.31e-05	12	90	3	M47369
Pathway	BIOCARTA_BARRESTIN_PATHWAY	KCNA1 KCNA2 KCNA3	5.31e-05	12	90	3	M7772
Pathway	KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY	KRAS NRAS HRAS	5.31e-05	12	90	3	M47815
Pathway	REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS	KRAS NRAS HRAS	5.31e-05	12	90	3	M29851
Pathway	WP_RALA_DOWNSTREAM_REGULATED_GENES	KRAS NRAS HRAS	5.31e-05	12	90	3	M39408
Pathway	REACTOME_NEURONAL_SYSTEM	KRAS NRAS CACNG8 KCNA1 KCNA2 KCNA3 KCNJ6 KCNJ9 HRAS PLCB3 CACNG4	5.95e-05	411	90	11	M735
Pathway	PID_MAPK_TRK_PATHWAY	KRAS NRAS MAPK14 HRAS	6.22e-05	34	90	4	M270
Pathway	WP_GLYCOGEN_METABOLISM	PPP2R2A PPP2R2B PPP2R2C PPP2R3A	6.22e-05	34	90	4	MM15985
Pathway	KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY	KRAS NRAS HRAS	6.87e-05	13	90	3	M47594
Pathway	WP_RAC1PAK1P38MMP2_PATHWAY	KRAS NRAS MAPK14 HRAS MAPK11	7.20e-05	68	90	5	M39456
Pathway	REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES	KRAS NRAS HRAS	8.71e-05	14	90	3	M27734
Pathway	BIOCARTA_BARR_MAPK_PATHWAY	KCNA1 KCNA2 KCNA3	8.71e-05	14	90	3	M668
Pathway	KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY	KRAS NRAS HRAS	8.71e-05	14	90	3	M47364
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY	KRAS NRAS HRAS	8.71e-05	14	90	3	M47365
Pathway	KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY	KRAS NRAS HRAS	8.71e-05	14	90	3	M47366
Pathway	KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY	KRAS NRAS HRAS	8.71e-05	14	90	3	M47390
Pathway	KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY	KRAS NRAS HRAS	8.71e-05	14	90	3	M47378
Pathway	REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING	KRAS NRAS HRAS	8.71e-05	14	90	3	M569
Pathway	PID_TCR_RAS_PATHWAY	KRAS NRAS HRAS	8.71e-05	14	90	3	M134
Pathway	KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY	KRAS NRAS HRAS	8.71e-05	14	90	3	M47488
Pathway	REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING	KRAS NRAS HRAS	8.71e-05	14	90	3	M719
Pathway	WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY	KRAS NRAS HRAS PLCB3	1.08e-04	39	90	4	M39905
Pathway	REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII	KRAS NRAS HRAS	1.08e-04	15	90	3	M29701
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY	KRAS NRAS HRAS	1.08e-04	15	90	3	M47367
Pathway	KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY	KRAS NRAS HRAS	1.08e-04	15	90	3	M47389
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY	KRAS NRAS HRAS	1.08e-04	15	90	3	M47375
Pathway	KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY	KRAS NRAS HRAS	1.08e-04	15	90	3	M47380
Pathway	KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY	KRAS NRAS HRAS	1.08e-04	15	90	3	M47592
Pathway	KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY	KRAS NRAS HRAS	1.08e-04	15	90	3	M47593
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY	KRAS NRAS HRAS	1.08e-04	15	90	3	M47640
Pathway	KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY	KRAS NRAS HRAS	1.08e-04	15	90	3	M47485
Pathway	KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY	KRAS NRAS HRAS	1.08e-04	15	90	3	M47473
Pathway	KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY	KRAS NRAS HRAS	1.08e-04	15	90	3	M47474
Pathway	KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY	KRAS NRAS HRAS	1.08e-04	15	90	3	M47475
Pathway	KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY	KRAS NRAS HRAS	1.08e-04	15	90	3	M47480
Pathway	KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY	KRAS NRAS HRAS	1.08e-04	15	90	3	M47495
Pathway	KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY	KRAS NRAS HRAS	1.08e-04	15	90	3	M47496
Pathway	KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY	KRAS NRAS HRAS	1.08e-04	15	90	3	M47497
Pathway	KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY	KRAS NRAS HRAS	1.08e-04	15	90	3	M47472
Pathway	KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY	KRAS NRAS HRAS	1.08e-04	15	90	3	M47535
Pathway	KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY	KRAS NRAS HRAS	1.08e-04	15	90	3	M47531
Pathway	BIOCARTA_AMAN_PATHWAY	MAN2A2 FUT9 FUT5	1.08e-04	15	90	3	M22009
Pathway	REACTOME_SIGNALING_BY_NTRKS	KRAS RAPGEF1 MAPK14 HRAS MAPK11	1.15e-04	75	90	5	MM14652
Pathway	WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION	PPP2R2A PPP2R2B PPP2R2C PPP2R3A	1.19e-04	40	90	4	M39595
Pathway	KEGG_VEGF_SIGNALING_PATHWAY	KRAS NRAS MAPK14 HRAS MAPK11	1.23e-04	76	90	5	M1749
Pathway	KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY	KRAS NRAS HRAS	1.33e-04	16	90	3	M47363
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY	KRAS NRAS HRAS	1.33e-04	16	90	3	M47373
Pathway	KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY	KRAS NRAS HRAS	1.33e-04	16	90	3	M47381
Pathway	KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY	KRAS NRAS HRAS	1.33e-04	16	90	3	M47804
Pathway	KEGG_MEDICUS_ENV_FACTOR_E2_TO_RAS_ERK_SIGNALING_PATHWAY	KRAS NRAS HRAS	1.33e-04	16	90	3	M47801
Pathway	REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING	KRAS NRAS HRAS	1.33e-04	16	90	3	M562
Pathway	REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS	KRAS NRAS HRAS	1.33e-04	16	90	3	M29847
Pathway	KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY	KRAS NRAS HRAS	1.33e-04	16	90	3	M47483
Pathway	REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS	KRAS NRAS HRAS	1.33e-04	16	90	3	M41733
Pathway	KEGG_MEDICUS_REFERENCE_AGE_RAGE_SIGNALING_PATHWAY	KRAS NRAS HRAS	1.33e-04	16	90	3	M47682
Pathway	KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY	KRAS NRAS MAPK14 HRAS MAPK11	1.47e-04	79	90	5	M11816
Pubmed	Cytoprotective effect of the small GTPase RhoB expressed upon treatment of fibroblasts with the Ras-glucosylating Clostridium sordellii lethal toxin.	KRAS NRAS MAPK14 HRAS	6.95e-10	5	121	4	22982107
Pubmed	Activation of protein phosphatase-2A1 by HIV-1 Vpr cell death causing peptide in intact CD(4+) T cells and in vitro.	PPP2R2A PPP2R2B PPP2R2C PPP2R3A	6.95e-10	5	121	4	15578586
Pubmed	HSF1 transcriptional activity is modulated by IER5 and PP2A/B55.	PPP2R2D PPP2R2A PPP2R2B PPP2R2C	4.84e-09	7	121	4	25816751
Pubmed	Akt-dependent Pp2a activity is required for epidermal barrier formation during late embryonic development.	PPP2R2D PPP2R2A PPP2R2B PPP2R2C	1.73e-08	9	121	4	19762425
Pubmed	Impaired OTUD7A-dependent Ankyrin regulation mediates neuronal dysfunction in mouse and human models of the 15q13.3 microdeletion syndrome.	ARHGAP39 FNBP1L PPP2R2B CACNG8 KCNA1 KCNA2 KCNA3 NETO2 CACNG4	3.27e-08	197	121	9	36604605
Pubmed	Diagnostic Value of RAS Mutations in Indeterminate Thyroid Nodules.	KRAS NRAS HRAS	4.11e-08	3	121	3	28116986
Pubmed	RAS gene mutations and histomorphometric measurements in oral squamous cell carcinoma.	KRAS NRAS HRAS	4.11e-08	3	121	3	37013448
Pubmed	Structure of the 55-kDa regulatory subunit of protein phosphatase 2A: evidence for a neuronal-specific isoform.	PPP2R2A PPP2R2B PPP2R3A	4.11e-08	3	121	3	1849734
Pubmed	Mutations of RAS gene family in specimens of bladder cancer.	KRAS NRAS HRAS	4.11e-08	3	121	3	19101897
Pubmed	Enhanced MET Translation and Signaling Sustains K-Ras-Driven Proliferation under Anchorage-Independent Growth Conditions.	KRAS NRAS HRAS	4.11e-08	3	121	3	25977330
Pubmed	Promoter hypomethylation as potential confounder of Ras gene overexpression and their clinical significance in subsets of urothelial carcinoma of bladder.	KRAS NRAS HRAS	4.11e-08	3	121	3	33620658
Pubmed	A comprehensive survey of Ras mutations in cancer.	KRAS NRAS HRAS	4.11e-08	3	121	3	22589270
Pubmed	A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation.	KRAS NRAS HRAS	4.11e-08	3	121	3	23496764
Pubmed	Distribution of p21ras during primary palate formation of non-cleft and cleft strains of mice.	KRAS NRAS HRAS	4.11e-08	3	121	3	7776260
Pubmed	The small GTPases K-Ras, N-Ras, and H-Ras have distinct biochemical properties determined by allosteric effects.	KRAS NRAS HRAS	4.11e-08	3	121	3	28630043
Pubmed	Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer.	KRAS NRAS HRAS	4.11e-08	3	121	3	28259994
Pubmed	The variable phenotype and low-risk nature of RAS-positive thyroid nodules.	KRAS NRAS HRAS	4.11e-08	3	121	3	26253102
Pubmed	Frequency of RAS gene mutation and its cooperative genetic events in Southeast Asian adult acute myeloid leukemia.	KRAS NRAS HRAS	4.11e-08	3	121	3	16573741
Pubmed	Activated k-ras, but not h-ras or N-ras, regulates brain neural stem cell proliferation in a raf/rb-dependent manner.	KRAS NRAS HRAS	4.11e-08	3	121	3	25788415
Pubmed	Analysis of k-ras nuclear expression in fibroblasts and mesangial cells.	KRAS NRAS HRAS	4.11e-08	3	121	3	20090846
Pubmed	Comparison of liver oncogenic potential among human RAS isoforms.	KRAS NRAS HRAS	4.11e-08	3	121	3	26799184
Pubmed	A pericyte origin of spinal cord scar tissue.	KRAS NRAS HRAS	4.11e-08	3	121	3	21737741
Pubmed	Ras isoforms: signaling specificities in CD40 pathway.	KRAS NRAS HRAS	4.11e-08	3	121	3	31906952
Pubmed	Partial functional overlap of the three ras genes in mouse embryonic development.	KRAS NRAS HRAS	4.11e-08	3	121	3	18059342
Pubmed	Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series.	KRAS NRAS HRAS	4.11e-08	3	121	3	23240926
Pubmed	Prevalence of RAS point mutations in papillary thyroid carcinoma; a novel mutation at codon 31 of K-RAS.	KRAS NRAS HRAS	4.11e-08	3	121	3	17943694
Pubmed	Absolute Quantification of Endogenous Ras Isoform Abundance.	KRAS NRAS HRAS	4.11e-08	3	121	3	26560143
Pubmed	Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma.	KRAS NRAS HRAS	4.11e-08	3	121	3	17712732
Pubmed	Comprehensive survey of HRAS, KRAS, and NRAS mutations in proliferative thyroid lesions from an ethnically diverse population.	KRAS NRAS HRAS	4.11e-08	3	121	3	24222113
Pubmed	Deciphering the RAS/ERK pathway in vivo.	KRAS NRAS HRAS	4.11e-08	3	121	3	28202657
Pubmed	Mutational analysis of K-ras and Ras protein expression in larynx squamous cell carcinoma.	KRAS NRAS HRAS	4.11e-08	3	121	3	16761621
Pubmed	Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis.	KRAS NRAS HRAS	4.11e-08	3	121	3	22945650
Pubmed	Activation of RAS family genes in urothelial carcinoma.	KRAS NRAS HRAS	4.11e-08	3	121	3	19303097
Pubmed	Brain protein phosphatase 2A: developmental regulation and distinct cellular and subcellular localization by B subunits.	PPP2R2A PPP2R2B PPP2R2C	4.11e-08	3	121	3	9514514
Pubmed	The spatiotemporal regulation of RAS signalling.	KRAS NRAS HRAS	4.11e-08	3	121	3	27911734
Pubmed	Absence of oncogenic mutations of RAS family genes in soft tissue sarcomas of 100 Japanese patients.	KRAS NRAS HRAS	4.11e-08	3	121	3	20150643
Pubmed	Silencing the expression of Ras family GTPase homologues decreases inflammation and joint destruction in experimental arthritis.	KRAS NRAS HRAS	4.11e-08	3	121	3	20971740
Pubmed	Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinoma.	KRAS NRAS HRAS	4.11e-08	3	121	3	27119512
Pubmed	A family of three mouse potassium channel genes with intronless coding regions.	KCNA1 KCNA2 KCNA3	4.11e-08	3	121	3	2305265
Pubmed	K-ras is an essential gene in the mouse with partial functional overlap with N-ras.	KRAS NRAS HRAS	4.11e-08	3	121	3	9334313
Pubmed	Ras effectors and their role in mitogenesis and oncogenesis.	KRAS NRAS MAPK14 HRAS	6.75e-08	12	121	4	9297626
Pubmed	Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29.	PPP2R2A PPP2R2B PPP2R2C PPP2R3A	9.73e-08	13	121	4	18971272
Pubmed	Increasing the ratio of PP2A core enzyme to holoenzyme inhibits Tat-stimulated HIV-1 transcription and virus production.	PPP2R2A PPP2R2B PPP2R2C PPP2R3A	1.36e-07	14	121	4	9400615
Pubmed	Dephosphorylation of CDK9 by protein phosphatase 2A and protein phosphatase-1 in Tat-activated HIV-1 transcription.	PPP2R2A PPP2R2B PPP2R2C PPP2R3A	1.36e-07	14	121	4	16048649
Pubmed	Direct activation of protein phosphatase-2A0 by HIV-1 encoded protein complex NCp7:vpr.	PPP2R2A PPP2R2B PPP2R2C PPP2R3A	1.36e-07	14	121	4	9013886
Pubmed	The RAS-Effector Interface: Isoform-Specific Differences in the Effector Binding Regions.	KRAS NRAS HRAS	1.64e-07	4	121	3	27936046
Pubmed	Reducing Pericyte-Derived Scarring Promotes Recovery after Spinal Cord Injury.	KRAS NRAS HRAS	1.64e-07	4	121	3	29502968
Pubmed	Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator.	KRAS NRAS HRAS	1.64e-07	4	121	3	7972015
Pubmed	Bcl-2 differentially targets K-, N-, and H-Ras to mitochondria in IL-2 supplemented or deprived cells: implications in prevention of apoptosis.	KRAS NRAS HRAS	1.64e-07	4	121	3	10490827
Pubmed	KCNE4 is an inhibitory subunit to Kv1.1 and Kv1.3 potassium channels.	KCNA1 KCNA2 KCNA3	1.64e-07	4	121	3	12944270
Pubmed	Tyrosine phosphorylation of RAS by ABL allosterically enhances effector binding.	KRAS NRAS HRAS	1.64e-07	4	121	3	25999467
Pubmed	Disruption of the mouse Rce1 gene results in defective Ras processing and mislocalization of Ras within cells.	KRAS NRAS HRAS	1.64e-07	4	121	3	10085069
Pubmed	Distinct origin and region-dependent contribution of stromal fibroblasts to fibrosis following traumatic injury in mice.	KRAS NRAS HRAS	1.64e-07	4	121	3	38849523
Pubmed	Targeted Long-Read Sequencing Decodes the Transcriptional Atlas of the Founding RAS Gene Family Members.	KRAS NRAS HRAS	1.64e-07	4	121	3	34948093
Pubmed	SUR-8, a conserved Ras-binding protein with leucine-rich repeats, positively regulates Ras-mediated signaling in C. elegans.	KRAS NRAS HRAS	1.64e-07	4	121	3	9674433
Pubmed	Ras membrane orientation and nanodomain localization generate isoform diversity.	KRAS NRAS HRAS	1.64e-07	4	121	3	20080631
Pubmed	Quantification of spatiotemporal patterns of Ras isoform expression during development.	KRAS NRAS HRAS	1.64e-07	4	121	3	28117393
Pubmed	Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression.	KRAS MAPK14 MAPK11	1.64e-07	4	121	3	26479921
Pubmed	Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration.	KRAS PPP2R2A PPP2R2B PPP2R2C	1.85e-07	15	121	4	16041367
Pubmed	Regulation of HIV-1 transcription by protein phosphatase 1.	PPP2R2A PPP2R2B PPP2R2C PPP2R3A	3.20e-07	17	121	4	17266553
Pubmed	[Action of protein phosphatase-1 on Tat-dependent HIV-1 transcription and its related inhibitors].	PPP2R2A PPP2R2B PPP2R2C PPP2R3A	3.20e-07	17	121	4	21351466
Pubmed	Pericyte-derived fibrotic scarring is conserved across diverse central nervous system lesions.	KRAS NRAS HRAS	4.09e-07	5	121	3	34535655
Pubmed	The complexity of Raf-1 regulation.	KRAS NRAS HRAS	4.09e-07	5	121	3	9069260
Pubmed	Impeded Nedd4-1-mediated Ras degradation underlies Ras-driven tumorigenesis.	KRAS NRAS HRAS	4.09e-07	5	121	3	24746824
Pubmed	Activated Ras induces lens epithelial cell hyperplasia but not premature differentiation.	KRAS NRAS HRAS	4.09e-07	5	121	3	15558479
Pubmed	K+ current diversity is produced by an extended gene family conserved in Drosophila and mouse.	KCNA1 KCNA2 KCNA3	4.09e-07	5	121	3	2333511
Pubmed	Contribution of Kv1.2 voltage-gated potassium channel to D2 autoreceptor regulation of axonal dopamine overflow.	KCNA1 KCNA2 KCNA3	4.09e-07	5	121	3	21233214
Pubmed	Subunit composition of Kv1 channels in human CNS.	KCNA1 KCNA2 KCNA3	4.09e-07	5	121	3	10428084
Pubmed	Signal transduction by the neurotrophin receptors.	KRAS NRAS RAPGEF1 HRAS	4.11e-07	18	121	4	9069267
Pubmed	Molecular mechanisms involved in HIV-1-Tat mediated inhibition of telomerase activity in human CD4(+) T lymphocytes.	PPP2R2A PPP2R2B PPP2R2C PPP2R3A	4.11e-07	18	121	4	23287597
Pubmed	Ppp2r2a Knockout Mice Reveal That Protein Phosphatase 2A Regulatory Subunit, PP2A-B55α, Is an Essential Regulator of Neuronal and Epidermal Embryonic Development.	PPP2R2D PPP2R2A PPP2R2B PPP2R2C	5.19e-07	19	121	4	32582689
Pubmed	Structure determination of the Ras-binding domain of the Ral-specific guanine nucleotide exchange factor Rlf.	KRAS NRAS HRAS	8.15e-07	6	121	3	9753431
Pubmed	Physical mapping of potassium channel gene clusters on mouse chromosomes three and six.	KCNA1 KCNA2 KCNA3	8.15e-07	6	121	3	9286706
Pubmed	FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy.	KRAS NRAS HRAS	8.15e-07	6	121	3	21072204
Pubmed	Stimulation of Ras guanine nucleotide exchange activity of Ras-GRF1/CDC25(Mm) upon tyrosine phosphorylation by the Cdc42-regulated kinase ACK1.	KRAS NRAS HRAS	8.15e-07	6	121	3	10882715
Pubmed	Glutamate transporter Slc1a3 mediates inter-niche stem cell activation during skin growth.	KRAS NRAS HRAS	8.15e-07	6	121	3	29615452
Pubmed	Differential K+ channel clustering activity of PSD-95 and SAP97, two related membrane-associated putative guanylate kinases.	KCNA1 KCNA2 KCNA3	8.15e-07	6	121	3	8938729
Pubmed	LZTR1 facilitates polyubiquitination and degradation of RAS-GTPases.	KRAS NRAS HRAS	8.15e-07	6	121	3	31337872
Pubmed	Truncation of the Shaker-like voltage-gated potassium channel, Kv1.1, causes megencephaly.	KCNA1 KCNA2 KCNA3	8.15e-07	6	121	3	14686897
Pubmed	Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1.	KRAS NRAS HRAS	1.42e-06	7	121	3	19487299
Pubmed	Clustering of Shaker-type K+ channels by interaction with a family of membrane-associated guanylate kinases.	KCNA1 KCNA2 KCNA3	1.42e-06	7	121	3	7477295
Pubmed	Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns.	KRAS NRAS HRAS	1.42e-06	7	121	3	20526288
Pubmed	H-, N- and Kras cooperatively regulate lymphatic vessel growth by modulating VEGFR3 expression in lymphatic endothelial cells in mice.	KRAS NRAS HRAS	1.42e-06	7	121	3	20179099
Pubmed	Absence of BRAF, NRAS, KRAS, HRAS mutations, and RET/PTC gene rearrangements distinguishes dominant nodules in Hashimoto thyroiditis from papillary thyroid carcinomas.	KRAS NRAS HRAS	1.42e-06	7	121	3	20012784
Pubmed	The structural basis of the activation of Ras by Sos.	KRAS NRAS HRAS	1.42e-06	7	121	3	9690470
Pubmed	Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation.	KRAS NRAS HRAS	1.42e-06	7	121	3	35904492
Pubmed	SmgGDS displays differential binding and exchange activity towards different Ras isoforms.	KRAS NRAS HRAS	1.42e-06	7	121	3	11948427
Pubmed	Molecular, morphologic, and outcome analysis of thyroid carcinomas according to degree of extrathyroid extension.	KRAS NRAS HRAS	1.42e-06	7	121	3	20860430
Pubmed	Mutational screening of RET, HRAS, KRAS, NRAS, BRAF, AKT1, and CTNNB1 in medullary thyroid carcinoma.	KRAS NRAS HRAS	1.42e-06	7	121	3	22199277
Pubmed	HIV-1 Vpr induces cell cycle G2 arrest in fission yeast (Schizosaccharomyces pombe) through a pathway involving regulatory and catalytic subunits of PP2A and acting on both Wee1 and Cdc25.	PPP2R2A PPP2R2B PPP2R2C PPP2R3A	1.96e-06	26	121	4	11531413
Pubmed	Nerve growth factor signaling, neuroprotection, and neural repair.	KRAS NRAS MAPK14 HRAS	1.96e-06	26	121	4	11520933
Pubmed	The role of Vpr in HIV-1 pathogenesis.	PPP2R2A PPP2R2B PPP2R2C	2.27e-06	8	121	3	15638722
Pubmed	Type 2A protein phosphatase, the complex regulator of numerous signaling pathways.	PPP2R2A PPP2R2C PPP2R3A	2.27e-06	8	121	3	11007961
Pubmed	Haplotype sharing suggests that a genomic segment containing six genes accounts for the pulmonary adenoma susceptibility 1 (Pas1) locus activity in mice.	KRAS NRAS HRAS	2.27e-06	8	121	3	15064703
Pubmed	Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival.	KRAS NRAS HRAS	2.27e-06	8	121	3	20150892
Pubmed	N-terminal PDZ-binding domain in Kv1 potassium channels.	KCNA1 KCNA2 KCNA3	2.27e-06	8	121	3	12435606
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	FLII TUBG2 ENPP2 NAP1L1 ACOT1 DMAP1 FN3K CYRIA TXNDC15 CELSR3 SNX6 HECTD2 KCNJ6 MKLN1 LRP1 EIF3D LNX1	2.36e-06	1285	121	17	35914814
Pubmed	Genomic organization, chromosomal localization, tissue distribution, and biophysical characterization of a novel mammalian Shaker-related voltage-gated potassium channel, Kv1.7.	KCNA1 KCNA2 KCNA3	3.40e-06	9	121	3	9488722
Pubmed	Signals transduced through the CD4 molecule interfere with TCR/CD3-mediated ras activation leading to T cell anergy/apoptosis.	KRAS NRAS HRAS	3.40e-06	9	121	3	9344703
Pubmed	The leucine-rich repeat protein SUR-8 enhances MAP kinase activation and forms a complex with Ras and Raf.	KRAS NRAS HRAS	3.40e-06	9	121	3	10783161
Interaction	MARK3 interactions	KRAS NRAS CASQ2 RHOQ PPP2R2A PPP2R2B KCNA3 AGO3 HRAS DDX60L OCLN	2.37e-07	246	119	11	int:MARK3
Interaction	GTSF1 interactions	KRAS NRAS MAPK14 HRAS	5.52e-07	12	119	4	int:GTSF1
Interaction	UNC5B interactions	KRAS NRAS TUBG1 RHOQ KCNA3 HRAS OCLN	6.52e-07	84	119	7	int:UNC5B
Interaction	IER5 interactions	PPP2R2D PPP2R2A PPP2R2B PPP2R2C	7.93e-07	13	119	4	int:IER5
Interaction	ADD1 interactions	KRAS NRAS RHOQ KCNA3 ATP6V1D HRAS PLCB3 OCLN LNX1	8.03e-07	171	119	9	int:ADD1
Interaction	ROBO1 interactions	KRAS NRAS RHOQ MAPK14 KCNA3 HRAS OCLN	1.62e-06	96	119	7	int:ROBO1
Interaction	DLG1 interactions	KRAS NRAS RHOQ MAPK14 KCNA1 KCNA2 KCNA3 KCNJ6 HRAS OCLN	1.63e-06	240	119	10	int:DLG1
Interaction	CACHD1 interactions	KRAS NRAS RHOQ KCNA3 HRAS OCLN	2.32e-06	65	119	6	int:CACHD1
Interaction	TMEM51 interactions	KRAS NRAS RHOQ KCNA3 HRAS PLCB3 OCLN	2.43e-06	102	119	7	int:TMEM51
Interaction	NCAPD3 interactions	KRAS DGCR2 PPP2R2D NCAPH PPP2R2A CD6 CACNG4 CLEC16A	3.37e-06	152	119	8	int:NCAPD3
Interaction	HEPH interactions	KRAS NRAS HRAS	3.96e-06	6	119	3	int:HEPH
Interaction	SERTAD4 interactions	PPP2R2D PPP2R2A PPP2R2B PPP2R2C	4.18e-06	19	119	4	int:SERTAD4
Interaction	NUMBL interactions	KRAS NRAS RHOQ KCNA3 HRAS OCLN LNX1	5.74e-06	116	119	7	int:NUMBL
Interaction	CDC42EP4 interactions	KRAS NRAS RHOQ HRAS OCLN LNX1	6.78e-06	78	119	6	int:CDC42EP4
Interaction	CASKIN2 interactions	KRAS P4HA3 RHOQ HRAS OCLN	8.30e-06	47	119	5	int:CASKIN2
Interaction	LRRC1 interactions	KRAS CACNG8 MAPK14 KCNJ6 CACNG4 NLRP5	9.73e-06	83	119	6	int:LRRC1
Interaction	PHLDB1 interactions	KRAS NRAS HRAS OCLN LNX1	1.02e-05	49	119	5	int:PHLDB1
Interaction	NDRG1 interactions	KRAS NRAS RHOQ PPP2R2A PPP2R2B KCNA3 HRAS OCLN LNX1	1.09e-05	235	119	9	int:NDRG1
Interaction	EPB41L5 interactions	KRAS NRAS NAP1L1 CASQ2 TTC4 RHOQ KCNA3 CD6 HRAS OCLN	1.11e-05	298	119	10	int:EPB41L5
Interaction	FAM135A interactions	KRAS NRAS RHOQ KCNA3 HRAS OCLN	1.19e-05	86	119	6	int:FAM135A
Interaction	CDC42EP1 interactions	KRAS NRAS RHOQ KCNA3 HRAS OCLN CLEC16A	1.28e-05	131	119	7	int:CDC42EP1
Interaction	IFNGR1 interactions	KRAS NRAS TSPAN3 RHOQ HRAS OCLN	1.36e-05	88	119	6	int:IFNGR1
Interaction	VANGL2 interactions	KRAS HFE NRAS RHOQ KCNA2 KCNA3 CD6 OCLN	1.43e-05	185	119	8	int:VANGL2
Interaction	KIDINS220 interactions	KRAS DGCR2 NRAS RHOQ KCNA3 TXNDC15 OCLN CLEC16A	1.54e-05	187	119	8	int:KIDINS220
Interaction	RAB11FIP5 interactions	KRAS PPP2R2D RHOQ PPP2R2A PPP2R2B DENND6A KCNA3 OCLN	1.54e-05	187	119	8	int:RAB11FIP5
Interaction	TBC1D10B interactions	KRAS RHOQ DENND6A KCNA3 HRAS OCLN	1.76e-05	92	119	6	int:TBC1D10B
Interaction	ROCK1 interactions	KRAS NRAS TBC1D5 RHOQ KCNA3 HRAS CFAP206 PLCB3	1.87e-05	192	119	8	int:ROCK1
Interaction	ADD2 interactions	KRAS NRAS RHOQ KCNA3 HRAS OCLN	1.87e-05	93	119	6	int:ADD2
Interaction	PPP4C interactions	KRAS PPP2R2D TUBG1 HDAC3 PPP2R2A PPP2R2B PPP2R2C	2.16e-05	142	119	7	int:PPP4C
Interaction	EFNB2 interactions	KRAS NRAS TSPAN3 RHOQ DENND6A HRAS OCLN	2.26e-05	143	119	7	int:EFNB2
Interaction	NIBAN2 interactions	KRAS NRAS PPP2R2B KCNA3 SNX6 HRAS OCLN	2.26e-05	143	119	7	int:NIBAN2
Interaction	TRPV2 interactions	KRAS NRAS HRAS	2.34e-05	10	119	3	int:TRPV2
Interaction	MARVELD2 interactions	KRAS NRAS RHOQ HRAS OCLN	2.78e-05	60	119	5	int:MARVELD2
Interaction	MPP7 interactions	KRAS NRAS RHOQ KCNA3 HRAS OCLN	3.00e-05	101	119	6	int:MPP7
Interaction	PABIR1 interactions	PPP2R2D PPP2R2A PPP2R2B PPP2R2C	3.21e-05	31	119	4	int:PABIR1
Interaction	DSC2 interactions	KRAS NRAS RHOQ DENND6A KCNA3 HRAS OCLN	3.49e-05	153	119	7	int:DSC2
Interaction	CCT7 interactions	KRAS FLNC PPP2R2D TUBG2 TUBG1 MKS1 HDAC3 PPP2R2A PPP2R2B PPP2R2C KCNA3 MIOS DDX20	3.57e-05	575	119	13	int:CCT7
Interaction	MARK2 interactions	KRAS NRAS RHOQ PPP2R2B KCNA3 AGO3 HRAS DDX60L OCLN	3.66e-05	274	119	9	int:MARK2
Interaction	CCT2 interactions	KRAS PPP2R2D TUBG2 TUBG1 MKS1 HDAC3 PPP2R2A PPP2R2B PPP2R2C KCNA3 MIOS ELF5 DDX20 LNX1	3.90e-05	666	119	14	int:CCT2
Interaction	PPFIA1 interactions	KRAS NRAS TUBG1 RHOQ KCNA3 HRAS OCLN LNX1	4.05e-05	214	119	8	int:PPFIA1
Interaction	PLEKHA1 interactions	KRAS NRAS RHOQ KCNA3 MSL3 OCLN	4.38e-05	108	119	6	int:PLEKHA1
Interaction	NECTIN2 interactions	KRAS NRAS RHOQ KCNA3 HRAS FUT9 OCLN	4.46e-05	159	119	7	int:NECTIN2
Interaction	PHACTR4 interactions	KRAS NRAS RHOQ KCNA3 HRAS OCLN	4.85e-05	110	119	6	int:PHACTR4
Interaction	USP6NL interactions	KRAS NRAS RHOQ KCNA3 HRAS OCLN	4.85e-05	110	119	6	int:USP6NL
Interaction	ZDHHC5 interactions	KRAS NRAS RHOQ KCNA3 HRAS OCLN	5.10e-05	111	119	6	int:ZDHHC5
Interaction	EFR3A interactions	KRAS NRAS RHOQ KCNA3 HRAS OCLN	5.10e-05	111	119	6	int:EFR3A
Interaction	MTMR1 interactions	KRAS NRAS RHOQ KCNA3 CD6 HRAS	5.10e-05	111	119	6	int:MTMR1
Interaction	KCNA4 interactions	KCNA1 KCNA2 KCNA3 ZFP64 LNX1	5.11e-05	68	119	5	int:KCNA4
Interaction	XPR1 interactions	KRAS DGCR2 NRAS RHOQ KCNA2 OCLN	5.37e-05	112	119	6	int:XPR1
Interaction	NOS1AP interactions	KRAS AKNAD1 RHOQ CD6 LRP1 OCLN	5.64e-05	113	119	6	int:NOS1AP
Interaction	NHSL3 interactions	KRAS NRAS POLR1A PPP2R2D HRAS OCLN	5.64e-05	113	119	6	int:NHSL3
Interaction	ZDHHC20 interactions	KRAS NRAS TSPAN3 HRAS	5.88e-05	36	119	4	int:ZDHHC20
Interaction	EFR3B interactions	KRAS NRAS RHOQ KCNA3 OCLN	6.29e-05	71	119	5	int:EFR3B
Interaction	SLC19A1 interactions	KRAS NRAS RHOQ HRAS OCLN	6.29e-05	71	119	5	int:SLC19A1
Interaction	DUSP10 interactions	PPP2R2D PPP2R2A MAPK14 LRP1 MAPK11	6.29e-05	71	119	5	int:DUSP10
Interaction	KIRREL1 interactions	KRAS DGCR2 NRAS RHOQ HRAS OCLN	6.53e-05	116	119	6	int:KIRREL1
Interaction	PI4KA interactions	KRAS DGCR2 NRAS RHOQ HRAS CACNG4 OCLN CLEC16A	6.53e-05	229	119	8	int:PI4KA
Interaction	IER2 interactions	PPP2R2D PPP2R2A PPP2R2B PPP2R2C	6.57e-05	37	119	4	int:IER2
Interaction	ITGB6 interactions	KRAS NRAS HRAS	6.97e-05	14	119	3	int:ITGB6
Interaction	SLC30A1 interactions	KRAS NRAS RHOQ KCNA3 HRAS OCLN	7.18e-05	118	119	6	int:SLC30A1
Interaction	SLC9A1 interactions	KRAS DGCR2 NRAS RHOQ MAPK14 HRAS	7.18e-05	118	119	6	int:SLC9A1
Interaction	NCAPD2 interactions	KRAS FLII FLNC NCAPH PPP2R2A KCNA3 EIF3D CLEC16A	7.60e-05	234	119	8	int:NCAPD2
Interaction	PLCH1 interactions	KRAS NRAS POLR1A KCNA3 OCLN	7.68e-05	74	119	5	int:PLCH1
Interaction	SERTAD2 interactions	PPP2R2D PPP2R2A PPP2R2B PPP2R2C	8.10e-05	39	119	4	int:SERTAD2
Interaction	SLC39A6 interactions	KRAS DGCR2 NRAS RHOQ HRAS OCLN	8.64e-05	122	119	6	int:SLC39A6
Interaction	PPFIBP1 interactions	KRAS NRAS RHOQ KCNA3 HRAS OCLN LNX1	8.77e-05	177	119	7	int:PPFIBP1
Interaction	NDRG3 interactions	KRAS NRAS HRAS LNX1	8.96e-05	40	119	4	int:NDRG3
Interaction	LCOR interactions	FLII TUBG2 ENPP2 ACOT1 HDAC3 CYRIA MAPK14 LRP1	9.60e-05	242	119	8	int:LCOR
Interaction	PSD3 interactions	KRAS NRAS RHOQ KCNA3 OCLN	9.87e-05	78	119	5	int:PSD3
Interaction	NBPF9 interactions	KRAS NBPF9	1.03e-04	3	119	2	int:NBPF9
Interaction	ROCK2 interactions	KRAS NRAS TUBG1 RHOQ KCNA3 HRAS PLCB3	1.04e-04	182	119	7	int:ROCK2
Interaction	ELMOD3 interactions	KRAS NRAS HRAS	1.06e-04	16	119	3	int:ELMOD3
Interaction	SAMSN1 interactions	KRAS NRAS HRAS	1.06e-04	16	119	3	int:SAMSN1
Interaction	CBARP interactions	KRAS NRAS RHOQ HRAS OCLN	1.11e-04	80	119	5	int:CBARP
Interaction	PACSIN2 interactions	KRAS NRAS TUBG1 RHOQ KCNA3 OCLN CLEC16A	1.16e-04	185	119	7	int:PACSIN2
Interaction	MARCKSL1 interactions	KRAS NRAS RHOQ MAPK14 ATP6V1D HRAS	1.18e-04	129	119	6	int:MARCKSL1
Interaction	SLC38A1 interactions	KRAS NRAS RHOQ KCNA3 HRAS OCLN	1.18e-04	129	119	6	int:SLC38A1
Interaction	SFT2D1 interactions	KRAS NRAS TSPAN3 HRAS	1.19e-04	43	119	4	int:SFT2D1
Interaction	TCP1 interactions	KRAS NRAS POLR1A PPP2R2D TUBG2 TUBG1 MKS1 HDAC3 PPP2R2A PPP2R2B PPP2R2C KCNA3	1.22e-04	561	119	12	int:TCP1
Interaction	EPB41L1 interactions	KRAS NRAS RHOQ KCNA3 CD6 HRAS OCLN	1.24e-04	187	119	7	int:EPB41L1
Interaction	CARMIL1 interactions	KRAS NRAS RHOQ KCNA3 LNX1	1.25e-04	82	119	5	int:CARMIL1
Interaction	FERMT2 interactions	KRAS NRAS RHOQ KCNA3 HRAS OCLN LNX1	1.32e-04	189	119	7	int:FERMT2
Interaction	TRPM7 interactions	KRAS NRAS RHOQ HRAS PLCB3 OCLN	1.33e-04	132	119	6	int:TRPM7
Interaction	SNX3 interactions	KRAS VPS26B TBC1D5 GLOD4 RHOQ SNX6 HRAS	1.36e-04	190	119	7	int:SNX3
Interaction	DSG2 interactions	KRAS NRAS RHOQ DENND6A KCNA3 HRAS OCLN CLEC16A	1.42e-04	256	119	8	int:DSG2
Interaction	CDCA4 interactions	PPP2R2D PPP2R2A PPP2R2B PPP2R2C	1.43e-04	45	119	4	int:CDCA4
Interaction	DAG1 interactions	KRAS HFE NRAS RHOQ ATP6V1D HRAS	1.45e-04	134	119	6	int:DAG1
Interaction	DEPDC1B interactions	KRAS DGCR2 NRAS RHOQ KCNA3 HRAS OCLN	1.46e-04	192	119	7	int:DEPDC1B
Interaction	SLC1A3 interactions	KRAS NRAS HRAS LNX1 CLEC16A	1.48e-04	85	119	5	int:SLC1A3
Interaction	MINK1 interactions	KRAS NRAS RAPGEF1 RHOQ KCNA3 HRAS OCLN	1.50e-04	193	119	7	int:MINK1
Interaction	ACBD3 interactions	KRAS FLII TBC1D22B NCAPH RHOQ PPP2R2A RPUSD2 OCLN	1.53e-04	259	119	8	int:ACBD3
Interaction	MPZL2 interactions	KRAS HRAS OCLN	1.54e-04	18	119	3	int:MPZL2
Interaction	SNX5 interactions	KRAS NRAS TBC1D5 SNX6 HRAS OCLN	1.64e-04	137	119	6	int:SNX5
Interaction	EHBP1 interactions	KRAS NRAS RHOQ KCNA3 HRAS OCLN	1.64e-04	137	119	6	int:EHBP1
Interaction	ATP2B4 interactions	KRAS DGCR2 NRAS ATP9A HRAS CACNG4 OCLN	1.65e-04	196	119	7	int:ATP2B4
Interaction	RALGAPA1 interactions	KRAS RHOQ KCNA3 HRAS OCLN	1.66e-04	87	119	5	int:RALGAPA1
Interaction	CTNND1 interactions	KRAS NRAS RHOQ KCNA3 HRAS ELF5 OCLN CLEC16A	1.79e-04	265	119	8	int:CTNND1
Interaction	ARL17A interactions	KRAS TSPAN3 KCNA2	1.82e-04	19	119	3	int:ARL17A
Interaction	GYPC interactions	KRAS NRAS HRAS	1.82e-04	19	119	3	int:GYPC
Interaction	EPB42 interactions	KRAS MAPK14 SNX6	1.82e-04	19	119	3	int:EPB42
Cytoband	Ensembl 112 genes in cytogenetic band chr1p13	NRAS AKNAD1 CASQ2 KCNA2 KCNA3 DDX20	2.17e-05	211	121	6	chr1p13
GeneFamily	WD repeat domain containing\|Protein phosphatase 2 regulatory subunits	PPP2R2D PPP2R2A PPP2R2B PPP2R2C PPP2R3A	5.23e-09	15	83	5	696
GeneFamily	Neuroblastoma breakpoint family	NBPF1 NBPF9 NBPF14	1.55e-04	23	83	3	662
GeneFamily	RAS type GTPase family	KRAS NRAS HRAS	3.82e-04	31	83	3	389
GeneFamily	Potassium voltage-gated channels	KCNA1 KCNA2 KCNA3	8.15e-04	40	83	3	274
GeneFamily	Mitogen-activated protein kinases	MAPK14 MAPK11	1.57e-03	13	83	2	651
GeneFamily	Fucosyltransferases\|Blood group antigens	FUT9 FUT5	1.57e-03	13	83	2	434
GeneFamily	Potassium voltage-gated channel subfamily J	KCNJ6 KCNJ9	2.40e-03	16	83	2	276
GeneFamily	NLR family	NLRC5 NLRP5	5.83e-03	25	83	2	666
GeneFamily	Tubulins	TUBG2 TUBG1	6.30e-03	26	83	2	778
GeneFamily	Calcium voltage-gated channel subunits	CACNG8 CACNG4	6.30e-03	26	83	2	253
GeneFamily	WD repeat domain containing	PPP2R2D PPP2R2A PPP2R2B PPP2R2C TLE6	7.13e-03	262	83	5	362
Coexpression	GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_6H_DN	ACE NCAPH NBAS NETO2 PREP KCNJ6 MAPK11 NNT	3.35e-06	195	120	8	M8160
Coexpression	GSE2128_C57BL6_VS_NOD_THYMOCYTE_DN	FLII CASQ2 TBC1D22B NBAS LINS1 CD6 HRAS PLCB3	4.04e-06	200	120	8	M6187
ToppCell	droplet-Limb_Muscle-nan-3m-Macroglial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL28A1 ACOT1 CPM PPP2R2B KCNA1 KCNA2 ART3	7.27e-07	184	121	7	da8d6e7944eb35e6cbea2feb7cbc2894787d723f
ToppCell	MS-CD8-antiviral_CD4\|MS / Condition, Cell_class and T cell subcluster	HFE NRAS PPP2R2B NLRC5 DDX20 PLCB3 ITPRIPL1	9.02e-07	190	121	7	8c831c4560b8e70f92b4c15644fea39f7f7afcf2
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Interneuron\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	TTC4 FN3K KCNA1 KCNA3 KCNJ9 PDZRN4	9.97e-07	121	121	6	b2d571f571133c281d72584fe925cebbd2317829
ToppCell	P03-Epithelial-epithelial_progenitor_cell-epi_progenitor\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	LPCAT1 TLE6 ELF5 CACNG4 C5 PDZRN4	3.62e-06	151	121	6	fce04bce66411c21cd5d4d41375f26f1f50f3348
ToppCell	droplet-Marrow-nan-24m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HFE ARHGEF28 ACE CYRIA HECTD2 LRP1	6.68e-06	168	121	6	e979a4fbeb9f21048b47d69e6da75c57650697f2
ToppCell	Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PPP2R2B PPP2R2C KCNJ6 NPC1L1 CACNG4 RIMS2	6.91e-06	169	121	6	96a2aec9acf8a6f966973c035e5ade456cf47772
ToppCell	droplet-Bladder-nan-24m-Epithelial-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	P4HA3 FBLN2 KCNA1 KCNA2 ART3 NPC1L1	9.59e-06	179	121	6	dfd9d29281510d32f1a2e8336d2e58ef496cfd1d
ToppCell	P28-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FLNC ARHGAP39 PPP2R2B KCNA1 KCNA2 ART3	9.90e-06	180	121	6	1e819c5c87704ec6535dfeaae56561895e239d07
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL28A1 P4HA3 PPP2R2B KCNA1 KCNA2 ART3	9.90e-06	180	121	6	d9c9399df3e2d9f23dbbfffb6cbe8404bf01e2b7
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL28A1 P4HA3 PPP2R2B KCNA1 KCNA2 ART3	9.90e-06	180	121	6	dad458398683ff80a6e207bdc08e257d1bb757d6
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Macroglial-Schwann_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL28A1 ACOT1 CPM KCNA1 KCNA2 ART3	1.05e-05	182	121	6	d568a8aec7e27ce632e248baea2ccd0e8dd255ac
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Macroglial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL28A1 ACOT1 CPM KCNA1 KCNA2 ART3	1.05e-05	182	121	6	e89cc30db8e5c77a8bbddd1d5a4b5af09f1ccd67
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Macroglial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL28A1 ACOT1 CPM KCNA1 KCNA2 ART3	1.05e-05	182	121	6	82ca6d5ed48b4c487ce00b9309255abb8f20b61d
ToppCell	droplet-Limb_Muscle-nan-3m-Macroglial-Schwann_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACOT1 CPM PPP2R2B KCNA1 KCNA2 ART3	1.09e-05	183	121	6	2cf36ad89584eb9f8b04de52a1b511b7f3527884
ToppCell	droplet-Limb_Muscle-nan-3m-Macroglial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACOT1 CPM PPP2R2B KCNA1 KCNA2 ART3	1.09e-05	183	121	6	98fee6838acfaee5e2e449ba088764ec06b8bc57
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL28A1 P4HA3 ACOT1 ARHGAP39 KCNA1 KCNA2	1.12e-05	184	121	6	e33bb572af9dfd11127105f1ac99bc958a7cafbb
ToppCell	PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ARHGEF28 CPM NTN4 FUT9 ELF5 C5	1.12e-05	184	121	6	fa4915b0498f3069fd5ef497286445528f75187e
ToppCell	droplet-Limb_Muscle-nan-24m-Macroglial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPM PPP2R2B PPP2R2C KCNA1 KCNA2 ART3	1.19e-05	186	121	6	ea936e66ae4b7b40564711fad60ac0137327995f
ToppCell	Anterior_Cingulate_gyrus_(CgG)\|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ARHGEF28 FNBP1L NBPF1 KCNA3 HECTD2 BAIAP3	1.19e-05	186	121	6	32af3f211f9ad5d5c6b86b83325cfbf2f8466b56
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Macroglial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL28A1 ACOT1 PPP2R2C KCNA1 KCNA2 ART3	1.23e-05	187	121	6	16e55d802fc4e71878305e61ad03806aabd59537
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Macroglial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGEF28 ACOT1 PPP2R2C KCNA1 KCNA2 ART3	1.27e-05	188	121	6	c2101ded71fb16b8ddbc1f883911b1ed2a533ffc
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-Schwann_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGEF28 ACOT1 PPP2R2C KCNA1 KCNA2 ART3	1.27e-05	188	121	6	3b8b9161f0fdcbde302ce5b4c0bc874628211109
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ARHGEF28 CPM NETO2 FUT9 C5 OCLN	1.31e-05	189	121	6	5d9da836ce4308b8458bb3be3871a0aca734b6cd
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Macroglial-Schwann_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LPCAT1 ACOT1 CPM KCNA1 KCNA2 ART3	1.35e-05	190	121	6	ff3dec5b45c6ea9b5319fb51a0198c6773b7be26
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Macroglial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LPCAT1 ACOT1 CPM KCNA1 KCNA2 ART3	1.35e-05	190	121	6	4971857eac9af17d66d673ed2ab7072639f60a10
ToppCell	(2)_Fibroblasts-(21)_Fibro-2\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	RHOQ NTN4 CYRIA FUT9 LRP1 LNX1	1.39e-05	191	121	6	5ee353c79055c08e8a3e2b43a0345bceb09f3890
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL28A1 CPM PPP2R3A RIMS2 LNX1 CLEC16A	1.39e-05	191	121	6	9032aa974aa1b7b1095b8d1b58dcb087358a5001
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL28A1 CPM PPP2R3A RIMS2 LNX1 CLEC16A	1.39e-05	191	121	6	5717809a1476c20f65bce722c5a57cff92ee0d7a
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ENPP2 ATP9A TSPAN3 PPP2R2C KCNA1 NETO2	1.51e-05	194	121	6	ba529c051f248d29f4222f4bc9801ba233859093
ToppCell	facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLNC ACE RHOQ NTN4 FBLN2 LRP1	1.51e-05	194	121	6	7b6ec45adb7ece3c8a7b78c5782413b5825effe2
ToppCell	PCW_13-14-Endothelial-Endothelial_immature-endo_immature_arterial1_(12)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ARHGEF28 CARD10 ACE NETO2 FUT9 MAPK11	1.51e-05	194	121	6	32ba2cf9b8726bc3c6e9dc24b54d22ff188bb12b
ToppCell	PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ARHGEF28 CPM NTN4 NETO2 ELF5 OCLN	1.51e-05	194	121	6	c47fc3f716ab091a39c20d7639ac783029589ee5
ToppCell	mild-B_cell\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RAPGEF1 GLOD4 FNBP1L ACE TTC4 OCLN	1.56e-05	195	121	6	1e5f1967bcc898318f4e970b844b4a944eb168e5
ToppCell	10x3'2.3-week_14-16-Mesenchymal_fibro\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	FLNC NTN4 FBLN2 KCNA1 C1R CACNG4	1.61e-05	196	121	6	ee45e4de9d706ec87094e87f47d3e514539b8092
ToppCell	10x3'2.3-week_14-16-Mesenchymal_fibro-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	FLNC NTN4 FBLN2 KCNA1 C1R CACNG4	1.61e-05	196	121	6	fa4a85a3cd52df0da5dfedc0e584e9df8c61ce89
ToppCell	PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ARHGEF28 CPM NTN4 NETO2 ELF5 OCLN	1.65e-05	197	121	6	22b26bac3a99b20c73bfa6e6f81026d064eaa9e8
ToppCell	Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control_saline / Treatment groups by lineage, cell group, cell type	LPCAT1 ARHGEF28 CPM NTN4 ELF5 C5	1.65e-05	197	121	6	44a59dfb889577b3160a5b13ada1276771a00241
ToppCell	Control_saline-Epithelial_alveolar-AT_2-AT2\|Control_saline / Treatment groups by lineage, cell group, cell type	LPCAT1 CPM FN3K NTN4 ELF5 C5	1.65e-05	197	121	6	f870a26f322668781e3d2832c5d9ef2c7c91011f
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	LPCAT1 ARHGEF28 NTN4 HECTD2 ELF5 C5	1.80e-05	200	121	6	e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae
ToppCell	368C-Fibroblasts-Fibroblast-F\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	TBC1D5 RAPGEF1 ART3 DDX60L OCLN	5.44e-05	149	121	5	f53151d9e5e724a61be0ee6a8c740d1990f28d5f
ToppCell	368C-Fibroblasts-Fibroblast-F-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	TBC1D5 RAPGEF1 ART3 DDX60L OCLN	5.44e-05	149	121	5	9286bc56ff2e245630537a0bda5f1a1e17be863a
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HFE CARD10 ACE HECTD2 LRP1	5.98e-05	152	121	5	82a493ffb2f1704cd6f68a82d970fe12f537d20e
ToppCell	18-Airway-Epithelial-Bud_tip_progenitor\|Airway / Age, Tissue, Lineage and Cell class	LPCAT1 CPM NTN4 ELF5 C5	7.39e-05	159	121	5	e715cadff8e7d5ebe4c2198dbdfd3ca41ecb8a6a
ToppCell	P28-Epithelial-epithelial_progenitor_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	LPCAT1 CASQ2 CPM KCNA1 C5	9.59e-05	168	121	5	03c95ad3684caec7a6d581006b237cc5fa230685
ToppCell	control-dn_T\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	NAP1L4 CD6 CELSR3 NLRC5 MAPK11	1.01e-04	170	121	5	839f62860b4a52d06e6a8fce7632195c7310b89d
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_1\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	FN3KRP CPM MKS1 NBPF14 CLEC16A	1.10e-04	173	121	5	efb8072475000888efe088d00e870c56ffad4172
ToppCell	wk_20-22-Epithelial-PNS\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	COL28A1 PPP2R2B KCNA2 ART3 RIMS2	1.10e-04	173	121	5	17b1a6b0318925d5d920f2c0a791745b9587ebef
ToppCell	E17.5-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	KRAS LPCAT1 CPM ELF5 C5	1.13e-04	174	121	5	68914ec843f58ecff3e6412544a341daf8a01cac
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	FN3KRP CPM MKS1 NBPF14 CLEC16A	1.13e-04	174	121	5	58300d64d3b6fd9ba1b6c87ea83b2777eb6be2f4
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW10-Neuronal-GABAergic_neurons\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	P4HA3 ACOT1 NTN4 CFAP206 PDZRN4	1.16e-04	175	121	5	d4ff1f197ad4086286e86817cbff24fa718293fc
ToppCell	P28-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	LPCAT1 CPM FDPS ELF5 C5	1.16e-04	175	121	5	8a4ed775ff973123dbcfe9c809959d11a62450c9
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HFE ACE RHOQ CYRIA LRP1	1.16e-04	175	121	5	cf53a15bfb37b6019e7052ffdf594a9ac040900e
ToppCell	facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ACOT1 DENND6A KCNA1 KCNA2 CELSR3	1.16e-04	175	121	5	bb898796662b97f7459b7dda7cecf6a9bde8b055
ToppCell	wk_20-22-Epithelial-PNS-Late_Schwann\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	COL28A1 PPP2R2B KCNA2 ART3 RIMS2	1.19e-04	176	121	5	81924471d8a8c5bd8eedf294c007e25b6cd3e417
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TUBG2 KCNA1 ART3 TLE6 PDZRN4	1.22e-04	177	121	5	6b4fe717928814dafcd13090b1c90ea973938c6d
ToppCell	3'-Adult-LargeIntestine-Hematopoietic-T_cells-SELL+_CD4_T\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MATN1 KCNA3 CD6 CELSR3 ELF5	1.22e-04	177	121	5	bb496fbec7cacc52847abe2b2714249c47879763
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Macroglial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL28A1 CPM KCNA1 KCNA2 ART3	1.26e-04	178	121	5	ef490b45901b2e6dedb519540fa3ae4e4db3a9ba
ToppCell	TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma\|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9	FN3KRP NAP1L4 HDAC3 HRAS MAPK11	1.29e-04	179	121	5	252328c9ce9bf61f741a4ebe170c93733c8747b6
ToppCell	3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL28A1 PPP2R2B KCNA2 ART3 FUT9	1.32e-04	180	121	5	38490017dd590e3fcfa7e88d8d15235d55f90cf1
ToppCell	Mesenchymal_cells-Stromal_fibro.\|Mesenchymal_cells / Lineage and Cell class	COL28A1 ENPP2 ACOT1 FBLN2 OCLN	1.36e-04	181	121	5	f8d914fdc06aaa75a4dc9158daf574ca28fa5432
ToppCell	PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	COL28A1 PPP2R2B ART3 RIMS2 PDZRN4	1.39e-04	182	121	5	bfb725fff3d20066d8ac0a6ba2f88498fcbd876e
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL28A1 PPP2R2B KCNA1 KCNA2 ART3	1.39e-04	182	121	5	812ff2a50a510b18d865e89465dba1754a08ef61
ToppCell	LPS_only-Epithelial_alveolar-AT_2-AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGEF28 NTN4 ELF5 C5 LNX1	1.39e-04	182	121	5	d1a1feef318062f25493355d7beee8e5fb0e4206
ToppCell	Control-Epithelial_alveolar-AT_2-AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LPCAT1 FN3K NTN4 ELF5 C5	1.39e-04	182	121	5	e97681a4102f3095d5d9e90ad70f1dc46e90983a
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TUBG2 ACOT1 PPP2R2B KCNA1 ART3	1.39e-04	182	121	5	c00e503f442d44fbae73c5e2dc85be69e294e67a
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CELSR3 KCNJ6 NPC1L1 CACNG4 RIMS2	1.43e-04	183	121	5	8820cfed27b292bc0bc9cde4005219ed41900552
ToppCell	mild-B_cell\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RAPGEF1 GLOD4 FNBP1L ACE TTC4	1.43e-04	183	121	5	175aaf8fbbff52eab87d78a49d5ab02cd489c438
ToppCell	Control-Epithelial_alveolar-AT_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LPCAT1 ARHGEF28 NTN4 ELF5 C5	1.47e-04	184	121	5	51e129b3fcc2df083eda05a3afe3717218b1e52b
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DGCR2 NAP1L4 NCAPH NBPF1 CD6	1.47e-04	184	121	5	bd786db4dc4edae6d5cfc0b69901983dea19f729
ToppCell	droplet-Limb_Muscle-nan-21m-Macroglial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPM ARHGAP39 KCNA1 KCNA2 ART3	1.51e-04	185	121	5	3d1353dbcb60e2531ef67e1bd218b7bc4d7c7c9b
ToppCell	droplet-Limb_Muscle-nan-21m-Macroglial-Schwann_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPM ARHGAP39 KCNA1 KCNA2 ART3	1.51e-04	185	121	5	995a8ddc3fd8e6879d8b5de8cbdefe232d34833b
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LPCAT1 ARHGEF28 NTN4 ELF5 C5	1.51e-04	185	121	5	0d2add28ac1f4fa6de7699be009bf8391badaf4c
ToppCell	Control-Epithelial_alveolar-AT_2-AT2_Progenitor\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LPCAT1 ARHGEF28 NTN4 ELF5 C5	1.51e-04	185	121	5	8ca1374501eca01d8468130b74d50abfd4329fbe
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGEF28 ARHGAP39 PPP2R2C KCNA1 ART3	1.51e-04	185	121	5	11c147f3f5570c4761d2bcff3bad28146b4a5861
ToppCell	wk_08-11-Epithelial-PNS-COL20A1+_Schwann\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	COL28A1 PPP2R2B KCNA2 ART3 RIMS2	1.51e-04	185	121	5	abec2a49fe0f0fa4cba49347207a1ee317333657
ToppCell	COVID-CD4-CD8_1\|COVID / Condition, Cell_class and T cell subcluster	NAP1L4 TUBG1 FN3K MAPK14 NBPF9	1.51e-04	185	121	5	c634bb04a081ae3214b68f6e4a147db5b2b916ed
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Macroglial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LPCAT1 CPM KCNA1 KCNA2 ART3	1.54e-04	186	121	5	d8d559daff4aeef334d403fde4e3ee2e4a6086d0
ToppCell	droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ACE PPP2R2C FBLN2 CASTOR1 OCLN	1.54e-04	186	121	5	9c7924875f70420720149287c500b4dfa8d24673
ToppCell	droplet-Lung-LUNG-1m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGEF28 CARD10 FN3K PPP2R2C FBLN2	1.54e-04	186	121	5	1e67bfb248366d7395efdd2d5e70a97bdb2e68af
ToppCell	droplet-Lung-1m-Endothelial-arterial_endothelial\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ARHGEF28 CARD10 FN3K PPP2R2C FBLN2	1.54e-04	186	121	5	ffbc78058be8f0dc2e0335cc4c3195a636d17721
ToppCell	PCW_07-8.5-Neuronal\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PPP2R2B KCNA2 ART3 RIMS2 PDZRN4	1.54e-04	186	121	5	7a4bb42f3f6a27b463e48eafc587d9ab3386f2fb
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CPM PPP2R3A MKLN1 FUT9 RIMS2	1.54e-04	186	121	5	f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCell	droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ARHGEF28 CARD10 FN3K PPP2R2C FBLN2	1.54e-04	186	121	5	ed924852cd7132c8f6703522037dc22bd2c83193
ToppCell	droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL28A1 PPP2R2B KCNA1 KCNA2 ART3	1.58e-04	187	121	5	6f7f293c9cf35261e0e3614e46ec1fb00a701b63
ToppCell	facs-Heart-LA-24m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ENPP2 ACE TSPAN3 FBLN2 LRP1	1.58e-04	187	121	5	f3ef3f5a761f8306edc39bf16e76e44aae6fa7f6
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CPM PPP2R3A MKLN1 FUT9 RIMS2	1.58e-04	187	121	5	c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCell	facs-Heart-LA-24m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ENPP2 ACE TSPAN3 FBLN2 LRP1	1.58e-04	187	121	5	1669df899b1759c338ffce196fe009840123cfcd
ToppCell	PCW_10-12-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PPP2R2B KCNJ6 CACNG4 RIMS2 BAIAP3	1.58e-04	187	121	5	98477ba04a42a8da80a72f41a182429f46283595
ToppCell	droplet-Limb_Muscle-nan-24m-Macroglial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPM PPP2R2C KCNA1 KCNA2 ART3	1.58e-04	187	121	5	a0bd2b0ec9e73521c245037b1dd51ff8cf24cbf5
ToppCell	droplet-Limb_Muscle-nan-24m-Macroglial-Schwann_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPM PPP2R2C KCNA1 KCNA2 ART3	1.58e-04	187	121	5	f2af79a20438108c814a73f9e24cd986d537237f
ToppCell	facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RAPGEF1 CARD10 ACE PPP2R2C FBLN2	1.58e-04	187	121	5	7170694a1b86fe8d84d96c880ffe57af09bdc026
ToppCell	facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLNC ENPP2 ACE NTN4 FBLN2	1.62e-04	188	121	5	aa516273cdde53c8c0295f06830972388f890c97
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CPM PPP2R3A MKLN1 FUT9 RIMS2	1.62e-04	188	121	5	af740fa78542438fdff627ea1f74f4eee43316be
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNG8 LRP1 CACNG4 LNX1 PDZRN4	1.62e-04	188	121	5	a244fcd092d5bd544e503366b1439b0fbc1ee00e
ToppCell	droplet-Heart-HEART-1m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL28A1 ARHGAP39 KCNA1 KCNA2 ART3	1.62e-04	188	121	5	921a2c9212a0f2a00fd72c594d80924f27e8b9b7
ToppCell	droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL28A1 P4HA3 KCNA1 KCNA2 ART3	1.62e-04	188	121	5	502045a39ffb1e92bd9499848368e8fa971edb88
ToppCell	(2)_Fibroblasts-(20)_Fibro-1\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	FLNC PPP2R2B FBLN2 LRP1 LNX1	1.62e-04	188	121	5	409a7b69d02e87084ca955e3fe6c77230dee8861
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNG8 LRP1 CACNG4 LNX1 PDZRN4	1.62e-04	188	121	5	c8530c9ff98666c64a94683261af4288cb790a7e
ToppCell	droplet-Limb_Muscle-nan-21m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNC ENPP2 RHOQ FBLN2 LRP1	1.66e-04	189	121	5	0a8b827bba1efd885ad6c06929251c741dc3a541
ToppCell	10x5'v1-week_14-16-Mesenchymal_fibro-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PPP2R2B KCNJ6 C1R CACNG4 PDZRN4	1.66e-04	189	121	5	eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0
Computational	Genes in the cancer module 59.	CASQ2 KCNA3 FUT9 MAPK11	4.17e-05	27	79	4	MODULE_59
Drug	L 744832	KRAS NRAS HRAS	5.69e-07	4	120	3	ctd:C096898
Drug	1,2,3,6-Tgg	KRAS ACE PREP	7.84e-06	8	120	3	CID000073178
Drug	Glimepiride [93479-97-1]; Up 200; 8.2uM; MCF7; HT_HG-U133A	ARHGEF28 ENPP2 CYRIA MAPK14 CD6 MAPK11 BAIAP3 PDZRN4	1.08e-05	199	120	8	4973_UP
Drug	AC1L32OA	KRAS NRAS HRAS	1.17e-05	9	120	3	CID000107745
Disease	Verrucous epidermal nevus	KRAS NRAS HRAS	5.77e-08	3	115	3	C0362030
Disease	Nevus Sebaceus of Jadassohn	KRAS NRAS HRAS	5.77e-08	3	115	3	C4552097
Disease	Organoid Nevus Phakomatosis	KRAS NRAS HRAS	5.77e-08	3	115	3	C0265329
Disease	Linear nevus sebaceous syndrome	KRAS NRAS HRAS	5.77e-08	3	115	3	cv:C4552097
Disease	Nevus sebaceous	KRAS NRAS HRAS	5.77e-08	3	115	3	C3854181
Disease	Inflammatory linear verrucous epidermal nevus	KRAS NRAS HRAS	5.77e-08	3	115	3	C0473574
Disease	SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME	KRAS NRAS HRAS	5.77e-08	3	115	3	163200
Disease	linear nevus sebaceous syndrome (is_implicated_in)	KRAS NRAS HRAS	5.77e-08	3	115	3	DOID:0111530 (is_implicated_in)
Disease	Noonan syndrome 3 (implicated_via_orthology)	KRAS NRAS HRAS	5.77e-08	3	115	3	DOID:0060581 (implicated_via_orthology)
Disease	Linear Verrucous Epidermal Nevus	KRAS NRAS HRAS	5.77e-08	3	115	3	C3179502
Disease	cervical cancer (implicated_via_orthology)	KRAS NRAS HRAS	5.77e-08	3	115	3	DOID:4362 (implicated_via_orthology)
Disease	autosomal dominant cerebellar ataxia (implicated_via_orthology)	PPP2R2D PPP2R2A PPP2R2B PPP2R2C	1.06e-07	12	115	4	DOID:1441 (implicated_via_orthology)
Disease	NEVUS, EPIDERMAL (disorder)	KRAS NRAS HRAS	5.73e-07	5	115	3	C0334082
Disease	Follicular thyroid carcinoma	KRAS NRAS HRAS	5.73e-07	5	115	3	C0206682
Disease	Hemimegalencephaly	KRAS NRAS HRAS	1.14e-06	6	115	3	C0431391
Disease	RASopathy (implicated_via_orthology)	KRAS NRAS HRAS	4.76e-06	9	115	3	DOID:0080690 (implicated_via_orthology)
Disease	prostate cancer (implicated_via_orthology)	KRAS NRAS P4HA3 HRAS	8.21e-06	33	115	4	DOID:10283 (implicated_via_orthology)
Disease	Noonan Syndrome 1	KRAS NRAS HRAS	9.30e-06	11	115	3	C4551602
Disease	Turner Syndrome, Male	KRAS NRAS HRAS	9.30e-06	11	115	3	C0041409
Disease	Female Pseudo-Turner Syndrome	KRAS NRAS HRAS	9.30e-06	11	115	3	C1527404
Disease	kidney cancer (implicated_via_orthology)	KRAS NRAS HRAS	9.30e-06	11	115	3	DOID:263 (implicated_via_orthology)
Disease	Cardiomyopathies	KRAS NRAS CASQ2 MAPK14 HRAS MAPK11	1.24e-05	130	115	6	C0878544
Disease	Thyroid Neoplasm	KRAS NRAS ENPP2 HRAS	1.31e-05	37	115	4	C0040136
Disease	RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER	KRAS NRAS	1.51e-05	2	115	2	614470
Disease	Autoimmune lymphoproliferative syndrome type 4	KRAS NRAS	1.51e-05	2	115	2	cv:C2674723
Disease	autoimmune lymphoproliferative syndrome type 4 (is_implicated_in)	KRAS NRAS	1.51e-05	2	115	2	DOID:0110117 (is_implicated_in)
Disease	MELANOCYTIC NEVUS SYNDROME, CONGENITAL	NRAS HRAS	1.51e-05	2	115	2	137550
Disease	Melanocytic nevus	NRAS HRAS	1.51e-05	2	115	2	cv:C0027962
Disease	RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER	KRAS NRAS	1.51e-05	2	115	2	C2674723
Disease	large congenital melanocytic nevus (is_implicated_in)	NRAS HRAS	1.51e-05	2	115	2	DOID:0111359 (is_implicated_in)
Disease	Large congenital melanocytic nevus	NRAS HRAS	1.51e-05	2	115	2	cv:C1842036
Disease	complex cortical dysplasia with other brain malformations 4 (implicated_via_orthology)	TUBG2 TUBG1	1.51e-05	2	115	2	DOID:0090138 (implicated_via_orthology)
Disease	RASopathy	KRAS NRAS HRAS	2.54e-05	15	115	3	cv:C5555857
Disease	Thyroid carcinoma	KRAS NRAS ENPP2 HRAS	2.63e-05	44	115	4	C0549473
Disease	GIANT PIGMENTED HAIRY NEVUS	NRAS HRAS	4.51e-05	3	115	2	C1842036
Disease	Noonan-Like Syndrome With Loose Anagen Hair	KRAS NRAS HRAS	5.34e-05	19	115	3	C3501846
Disease	Noonan syndrome-like disorder with loose anagen hair	KRAS NRAS HRAS	5.34e-05	19	115	3	C1843181
Disease	Cardio-facio-cutaneous syndrome	KRAS NRAS HRAS	5.34e-05	19	115	3	C1275081
Disease	Costello syndrome (disorder)	KRAS NRAS HRAS	5.34e-05	19	115	3	C0587248
Disease	leukemia (implicated_via_orthology)	KRAS NRAS HRAS	5.34e-05	19	115	3	DOID:1240 (implicated_via_orthology)
Disease	Splenomegaly	KRAS NRAS OCLN	8.41e-05	22	115	3	C0038002
Disease	LEOPARD Syndrome	KRAS NRAS HRAS	8.41e-05	22	115	3	C0175704
Disease	multiple myeloma (is_implicated_in)	KRAS HFE NRAS ACE	8.45e-05	59	115	4	DOID:9538 (is_implicated_in)
Disease	glucose-6-phosphate measurement	FN3KRP FN3K	8.99e-05	4	115	2	EFO_0010485
Disease	NEVUS, EPIDERMAL	NRAS HRAS	8.99e-05	4	115	2	162900
Disease	Malignant neoplasm of penis	KRAS HRAS	8.99e-05	4	115	2	C0153601
Disease	Penile Neoplasms	KRAS HRAS	8.99e-05	4	115	2	C0030849
Disease	Nevus, Keratinocytic, Nonepidermolytic	NRAS HRAS	8.99e-05	4	115	2	C4011754
Disease	BLADDER CANCER	KRAS HRAS	8.99e-05	4	115	2	109800
Disease	Epidermal nevus	NRAS HRAS	8.99e-05	4	115	2	cv:C0334082
Disease	Malignant tumor of urinary bladder	KRAS HRAS	8.99e-05	4	115	2	cv:C0005684
Disease	Thyroid cancer, nonmedullary, 2	NRAS HRAS	8.99e-05	4	115	2	cv:C4225426
Disease	Malignant tumor of cervix	KRAS HRAS	8.99e-05	4	115	2	C0007847
Disease	epidermal nevus (is_implicated_in)	NRAS HRAS	8.99e-05	4	115	2	DOID:0111162 (is_implicated_in)
Disease	THYROID CANCER, NONMEDULLARY, 2	NRAS HRAS	8.99e-05	4	115	2	188470
Disease	Noonan Syndrome	KRAS NRAS HRAS	1.10e-04	24	115	3	C0028326
Disease	THYROID CANCER, NONMEDULLARY, 2	NRAS HRAS	1.49e-04	5	115	2	C4225426
Disease	Malignant neoplasm of thyroid	KRAS NRAS	1.49e-04	5	115	2	C0007115
Disease	Cetuximab response	KRAS NRAS	1.49e-04	5	115	2	cv:CN077967
Disease	Cervix carcinoma	KRAS HRAS	1.49e-04	5	115	2	C0302592
Disease	Panitumumab response	KRAS NRAS	1.49e-04	5	115	2	cv:CN077999
Disease	response to silica exposure, pneumoconiosis	CPM PDZRN4	1.49e-04	5	115	2	EFO_0005853, MONDO_0015926
Disease	cardiomyopathy (implicated_via_orthology)	KRAS NRAS HRAS LRP1	1.74e-04	71	115	4	DOID:0050700 (implicated_via_orthology)
Disease	hypertrophic cardiomyopathy (implicated_via_orthology)	KRAS NRAS HRAS	1.96e-04	29	115	3	DOID:11984 (implicated_via_orthology)
Disease	colorectal cancer (implicated_via_orthology)	KRAS NRAS HRAS	2.17e-04	30	115	3	DOID:9256 (implicated_via_orthology)
Disease	Pleocytosis	KRAS NRAS	2.24e-04	6	115	2	C0151857
Disease	Autoimmune lymphoproliferative syndrome	KRAS NRAS	2.24e-04	6	115	2	cv:CN301239
Disease	Carcinoma in situ of uterine cervix	KRAS HRAS	2.24e-04	6	115	2	C0851140
Disease	seminoma (is_implicated_in)	KRAS HRAS	2.24e-04	6	115	2	DOID:4440 (is_implicated_in)
Disease	Leukocytosis	KRAS NRAS	2.24e-04	6	115	2	C0023518
Disease	intestinal cancer (implicated_via_orthology)	KRAS NRAS HRAS	2.63e-04	32	115	3	DOID:10155 (implicated_via_orthology)
Disease	Thyroid cancer, follicular	NRAS HRAS	3.12e-04	7	115	2	C2931367
Disease	Thyroid Gland Follicular Adenoma	KRAS ENPP2 HRAS	3.45e-04	35	115	3	C0151468
Disease	Alzheimer's disease biomarker measurement, brain volume measurement	KRAS NRAS	4.15e-04	8	115	2	EFO_0006514, EFO_0006930
Disease	heart disease (implicated_via_orthology)	KRAS NRAS HRAS	4.40e-04	38	115	3	DOID:114 (implicated_via_orthology)
Disease	Silicosis	CPM PDZRN4	5.32e-04	9	115	2	C0037116
Disease	Noonan syndrome	KRAS NRAS	5.32e-04	9	115	2	cv:C0028326
Disease	liver cirrhosis (is_implicated_in)	HFE ACE C5	6.35e-04	43	115	3	DOID:5082 (is_implicated_in)
Disease	thyroid gland papillary carcinoma (is_implicated_in)	NRAS HRAS	6.64e-04	10	115	2	DOID:3969 (is_implicated_in)
Disease	high grade glioma (implicated_via_orthology)	KRAS NRAS HRAS	6.80e-04	44	115	3	DOID:3070 (implicated_via_orthology)
Disease	response to angiotensin-converting enzyme inhibitor, Cough	PKD1L2 KCNA1 CACNG4	7.75e-04	46	115	3	EFO_0005325, HP_0012735
Disease	entorhinal cortical volume, Alzheimer's disease biomarker measurement	KRAS NRAS	8.09e-04	11	115	2	EFO_0005092, EFO_0006514
Disease	endometriosis (implicated_via_orthology)	KRAS HDAC3	8.09e-04	11	115	2	DOID:289 (implicated_via_orthology)
Disease	Neuroblastoma	KRAS NRAS HRAS	8.25e-04	47	115	3	C0027819
Disease	Alzheimer's disease biomarker measurement	KRAS NRAS CYRIA	8.78e-04	48	115	3	EFO_0006514
Disease	Pathological accumulation of air in tissues	PPP2R2A PPP2R2C	9.69e-04	12	115	2	C0013990
Disease	middle temporal gyrus volume measurement, Alzheimer's disease biomarker measurement	KRAS NRAS	1.14e-03	13	115	2	EFO_0006514, EFO_0010316
Disease	acute lymphoblastic leukemia (is_implicated_in)	KRAS HFE NRAS	1.31e-03	55	115	3	DOID:9952 (is_implicated_in)
Disease	Malformations of Cortical Development	TUBG1 HRAS	1.33e-03	14	115	2	C1955869
Disease	whole-brain volume, Alzheimer's disease biomarker measurement	KRAS NRAS	1.33e-03	14	115	2	EFO_0005089, EFO_0006514
Disease	Cortical Dysplasia	TUBG1 HRAS	1.33e-03	14	115	2	C0431380
Disease	Birth Weight	HFE ENPP2	1.33e-03	14	115	2	C0005612
Disease	Malignant Neoplasms	KRAS NRAS HRAS OCLN	1.61e-03	128	115	4	C0006826
Disease	pneumonia (is_implicated_in)	ACE C5	1.74e-03	16	115	2	DOID:552 (is_implicated_in)
Disease	dysmenorrheic pain measurement	KRAS NRAS	1.74e-03	16	115	2	EFO_0007889
Disease	proliferative diabetic retinopathy	TBC1D5 CPM NNT	1.76e-03	61	115	3	EFO_0009322
Disease	renal fibrosis (implicated_via_orthology)	KRAS ACE	1.97e-03	17	115	2	DOID:0050855 (implicated_via_orthology)
Disease	theta wave measurement	CACNG4 CLEC16A	1.97e-03	17	115	2	EFO_0006873
Disease	cervical artery dissection	LRP1 LNX1	1.97e-03	17	115	2	EFO_1000059
Disease	carcinoma (implicated_via_orthology)	KRAS NRAS HRAS	2.02e-03	64	115	3	DOID:305 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
YDHFFEDVYTLIPAV	TSPAN3	41	O60637
EYFEEAVNYLLSHPE	ACOT1	206	Q86TX2
EYNVYSTFQSHEPEF	PPP2R2B	66	Q00005
EYDVYSTFQSHEPEF	PPP2R2C	66	Q9Y2T4
FESDYEEESYHLAPE	BDP1	1881	A6H8Y1
EFYYPEHFTLLTGQE	CARD10	101	Q9BWT7
YNSPTFEDDLEHLYQ	ACE	231	P12821
YNVYSTFQSHEPEFD	PPP2R2A	71	P63151
HPVYDELFYFSVPAE	BAIAP3	1076	O94812
YYISTFNFDHALVPE	CASTOR1	296	Q8WTX7
EYNVYSTFQSHEPEF	PPP2R2D	76	Q66LE6
FYHIEYFLLPDDEEP	CFAP92	116	Q9ULG3
PYTLTFAELVEDYEH	DDX20	586	Q9UHI6
TVDTDITHPYEFDFY	AGO3	736	Q9H9G7
CPETATFLDTFHYYD	AOC1	391	P19801
TFLDTFHYYDADDPV	AOC1	396	P19801
SVHPDYRQDESYNFE	C1R	541	P00736
LFSNEEYYPAFEHQT	ELF5	36	Q9UKW6
AYSFAENPEHYIDIV	CFAP206	456	Q8IYR0
NHFVDEYDPTIEDSY	HRAS	26	P01112
NHFVDEYDPTIEDSY	KRAS	26	P01116
NHFVDEYDPTIEDSY	NRAS	26	P01111
FEASHYPDVYSREEL	RAX2	46	Q96IS3
HEFYEDNEYISSLPA	PDZRN4	376	Q6ZMN7
EFYEQCIAHYDSPEA	ARHGAP39	981	Q9C0H5
FHFEPNEYFTNEVLT	NAP1L1	216	P55209
QPAYSFYPEDEILHF	OCLN	41	Q16625
EDGFYEVDYASFHET	KCNJ9	311	Q92806
AEYHDDFFPESAYVA	MSL3P1	416	P0C860
PYIALYHDFVSDSEA	P4HA3	346	Q7Z4N8
LPEDAEFYFTYDGSH	ARHGEF28	26	Q8N1W1
GSDSDYEHYDFSAQP	CD6	481	P30203
LEFHFEPNDYFTNSV	NAP1L4	206	Q99733
EIENYPHFFLDFENA	CYRIA	11	Q9H0Q0
FAEEYLYPDQTHFES	LPCAT1	486	Q8NF37
SNFNYFYHRETEGEE	KCNA2	411	P16389
EALAHAYFSQYHDPE	MAPK11	301	Q15759
AYFSQYHDPEDEPEA	MAPK11	306	Q15759
PEEEFGHFYTQDCYV	FLII	921	Q13045
FNYFYHRETEGEEQA	KCNA1	411	Q09470
HDYIFYLNPAVSDQD	LINS1	26	Q8NG48
EIASEPVAEHYFYTA	MATN1	421	P21941
HSYFFEDTLDLTYEG	MAGEC3	521	Q8TD91
EVENHYTLSLPEDFY	nan	41	A8MVJ9
LFLEEDHYLAPDFYH	MGAT2	256	Q10469
VIFDPASFYGHSEYE	FN3KRP	231	Q9HA64
GPEDDHFVAELTYNY	GLOD4	76	Q9HC38
TLEDGFYEVDYNSFH	KCNJ6	341	P48051
AYFAQYHDPDDEPVA	MAPK14	306	Q16539
LPAVFLQYEEDSYSH	FDPS	376	P14324
HPFSIDVFEDYIYGV	LRP1	4091	Q07954
NYENYIPADSFIHVE	FUT9	276	Q9Y231
PYTDFYNSTLDHIDL	HECTD2	336	Q5U5R9
FYYEFESTQEPHLNL	DDX60L	371	Q5H9U9
RHYEDPYSYDQEVAE	FBLN2	191	P98095
ENHDGTFDIYYTAPE	FLNC	1696	Q14315
LAEYHDDFFPESAYV	MSL3	491	Q8N5Y2
SNFNYFYHRETEGEE	KCNA3	481	P22001
HSLEENHFYSYPEEV	LNX1	21	Q8TBB1
NHFYSYPEEVDDDLI	LNX1	26	Q8TBB1
LPDSHCEEYYTFFHL	NLRP5	571	P59047
SYVYAEEPNIDIHNF	ATP9A	221	O75110
GYVDDQLFVFYDHES	HFE	51	Q30201
TYDTYQHVPVESFAE	NBAS	1491	A2RRP1
PDSFQHYRSVFYSFE	NBPF1	1166	Q3BBV0
EDINQITDYFSYEHF	PPP2R3A	886	Q06190
SEYFEYFAPDFTLHP	HDAC3	326	O15379
YLSPESDHDTVFQYL	NLRC5	281	Q86WI3
LEDNDPFAQYHYLVT	PKD1L2	1381	Q7Z442
TYTYADTPDDFQLHN	GBA	171	P04062
HEPQFYEDSDHLSYR	RIMS2	311	Q9UQ26
PAVVAYEAFYQHSFA	NPC1L1	151	Q9UHC9
YPDVYRDETAVQDYH	PREP	6	P48147
YTEASDYIPDDHQDY	PLCB3	841	Q01970
DFPSQEALDSFYKHY	ITPRIPL1	161	Q6GPH6
EHDYFEFFSNDTSLY	UPF3B	76	Q9BZI7
HFPEDTDYDHDSAEY	CACNG8	106	Q8WXS5
PEHVYQFDDFFTLQD	COL28A1	956	Q2UY09
FPFEDYSQHIYRTIS	FNBP1L	281	Q5T0N5
TPDDDVFQYLAHTYA	CPM	216	P14384
FPEDNDYDHDSSEYL	CACNG4	86	Q9UBN1
PVYSEQEYQLYLHDD	DMAP1	136	Q9NPF5
HFSVSIEPEYNFIGY	C5	226	P01031
GSQYAYFHEEDESSF	EIF3D	66	O15371
YFSDFRPYFTIHDSE	DENND6A	321	Q8IWF6
FSEHTTYKQEDLPYD	AKNAD1	6	Q5T1N1
YEASIHPDSVFYDPA	DGCR2	451	P98153
TEGPFFSEVVAYYEH	MAN2A2	836	P49641
SEYYKAFEEAAEHFQ	CASQ2	176	O14958
LDLNDVTHVYNYDFP	DDX53	531	Q86TM3
ATSHIFYEPDAYDDL	ELP5	291	Q8TE02
PAYDPDVSDHLFYSF	CELSR3	1196	Q9NYQ7
PDHERPSVYAFYSEQ	ENPP2	296	Q13822
EYIIEYPHFATDAAA	NNT	721	Q13423
FYLAFENSLHPDYIT	FUT5	256	Q11128
VSFGDEHFAETSYYF	RPUSD2	121	Q8IZ73
EEYVPTVFDHYAVSV	RHOQ	36	P17081
REIHPFIDDYQYDTE	POLR1A	1506	O95602
FGFIEQYYDSRNEEH	TBC1D22B	246	Q9NU19
LNEEPQHFTHYAIYD	NTN4	241	Q9HB63
ELPDSFQHYRSVFYS	NBPF9	1061	P0DPF3
ELPDSFQHYRSVFYS	NBPF14	871	Q5TI25
YLNDFFSYDVDSDHV	MKLN1	481	Q9UL63
IIYDPASFYGHSEFE	FN3K	231	Q9H479
FESVIHEFDPYFNYR	STT3A	41	P46977
IPDTVTQYSELYHDF	SLC3A1	336	Q07837
LTFDEHYYIEPSFEC	NETO2	86	Q8NC67
DFVEEYFLHSLPYID	B3GALT9	31	A8MXE2
TEHYEEIEDYDYNNP	NCAPH	541	Q15003
YHALDSPDDDYHALF	CLEC16A	486	Q2KHT3
DFEFTHVEKPYESYT	VPS26B	106	Q4G0F5
TVDPYFHDRVASFYE	MIOS	231	Q9NXC5
EYDNLYVHFFVELPT	MKS1	326	Q9NXB0
ETLDHYDPDYEFLQQ	RAPGEF1	381	Q13905
FFYQADDEHYIPRAV	TUBG1	51	P23258
LPVFEHYHEGTDSYE	ATP6V1D	106	Q9Y5K8
AGAHFPDREEEYYTE	TXNDC15	136	Q96J42
HSERQELFDEDYDYP	SUCO	466	Q9UBS9
LHDSFVENEDYAGYI	SNX6	76	Q9UNH7
FFYQADDEHYIPRAV	TUBG2	51	Q9NRH3
LNPEYLEHDAYAVFS	TBC1D5	241	Q92609
DVHLAYDTPFVYAEV	TGM7	386	Q96PF1
SNDPYCFVEFYEHRD	TIAL1	46	Q01085
LYPEYAQSDFISAFH	TTC4	281	O95801
SAIHIEFTEYYFPDN	UHRF1BP1	506	Q6BDS2
VSAPEFVFEHGYQTY	ZFP64	96	Q9NTW7
FVFEHGYQTYLPTES	ZFP64	101	Q9NTW7
FSPHFAAELESIYYS	TLE6	46	Q9H808
YISEAQEQTPFYHLF	ART3	101	Q13508